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Abstract
Sudden Unexpected Death in Infancy (SUDI) refers to any such sudden demise in a
child. If the child dies while asleep within the first year of life, and if no conclusive
cause of death can be ascertained by means of complete autopsy and investigation into
the circumstances surrounding death, including visit of the death scene, such a case is
classified as one of Sudden Infant Death Syndrome (SIDS). By South African law, a
full medico-legal autopsy is mandated in cases where the cause of death is not evident
– including cases of possible SIDS.
There can be little doubt that viral infection can be a cause of death in cases of
supposed SUDI. At the Tygerberg medico-legal (forensic) laboratory, the evaluation
of lung tissue for the presence of fatal viral lung infections forms part of the
institutional protocol for the examination of SUDI cases. Lung samples of these SUDI
cases are routinely tested for the presence of Cytomegalovirus (CMV), adenovirus
and respiratory syncytial virus (RSV) by means of shell vial cultures. In a
retrospective pilot study of 366 SUDI case files from Tygerberg Hospital, Western
Cape, from 2004 – 2006, it was evident that in only 13.9% of possible SIDS cases,
positive results for one or more of the aforementioned viruses were obtained.
We hypothesise that the current method of virus detection, together with other factors
such as the interval between death and post mortem examination, transport time of the
specimens to the laboratory etc. might not be optimal to give a realistic picture of
death in infancy caused by viral pulmonary infection. As other test modalities exist
for the diagnosis of pulmonary viral infections, these methods were compared in
terms of positive yield and association with viral pneumonitis, keeping the cost and
time needed for each assay in mind.
A total of 82 samples were collected over an 8 month period and routine shell vial
cultures were done, followed by real-time Polymerase Chain Reaction (PCR) and
immunohistochemical (IHC) staining of the lung sections with consensus pathology
opinion. As expected, the real-time PCR method was much more better suited for
identifying positive samples than shell vials (35% vs. 3.7% respectively). IHC
staining also aided the pathologist in diagnosing viral infections microscopically. We
expect the findings to be instrumental in streamlining not only our institutional SIDS
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investigation protocol, but also the development of a standardised national SIDS
investigation protocol.
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Opsomming
“Sudden Unexpected Death in Infancy” (SUDI) verwys na enige skielike sterfte van
‘n kind. Indien die kind sterf tydens sy/haar slaap periode en geen oortuigende
oorsaak van dood bepaal kan word deur middel van ’n volledige nadoodse ondersoek
en ondersoek na die omstandighede tydens die dood, insluitend ’n besoek aan die
doodstoneel nie, word so ’n geval as Wiegiedood (SIDS) geklassifiseer. Suid-
Afrikaanse wetgewing vereis ’n volledige medies-geregtelike nadoodse ondersoek in
gevalle waar die oorsaak van dood onbekend is – insluitend gevalle van moontlike
Wiegiedood.
Daar is min twyfel dat virusinfeksie ‘n oorsaak van, of bydraende faktor tot dood kan
wees in gevalle van moontlike SUDI. By die Tygerberg forensiese laboratorium vorm
die evaluasie van long weefsel vir die teenwoordigheid van dodelike virusinfeksies
deel van die institusionele protokol vir die ondersoek van SUDI gevalle. Long
monsters van hierdie SUDI gevalle ondergaan roetine toetse vir die teenwoordigheid
van sitomegaalvirus, respiratoriese sinsitialevirus en adenovirus deur middel van
selkulture (“shell vial cultures”). In ‘n retrospektiewe steekproef van 366 SUDI
gevalle by Tygerberg Hospitaal, Wes-Kaap van 2004 – 2006, is bevind dat in slegs
13.9% van moontlike SUDI gevalle die teenwoordigheid van een of meer van
bogenoemde virusse bevestig kon word. Ons hipotese is dat hierdie metode van virus
deteksie, tesame met ander faktore soos die tydsinterval tussen dood en nadoodse
ondersoek, tyd om monsters na die laboratorium te vervoer ens. moontlik nie optimaal
is om ‘n realistiese beeld van dood in babas as gevolg van pulmonale virusinfeksie te
gee nie. Aangesien ander toets modaliteite bestaan vir die diagnose van pulmonale
virusinfeksies, is hierdie metodes vergelyk in terme van positiewe opbrengs en
assosiasie met virale pneumonitis, teen ’n agtergrond van die koste en tyd benodig per
toets.
’n Totaal van 82 monsters is oor ‘n 8 maande periode versamel en roetine selkulture is
gedoen, gevolg deur “real-time” Polimerase Ketting Reaksie (PKR), asook
immunohistochemiese (IHC) kleuring van long snitte met patologiese verslae. Soos
vermoed, is gevind dat die real-time PKR metode baie meer akkuraat is om positiewe
monsters te identifiseer as roetine selkulture (35% vs 3.7% onderskeidelik). IHC
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kleuring het ook mikroskopiese diagnose van virale infeksies deur die patoloog
vergemaklik. Ons verwag dat hierdie bevindinge grootliks kan bydra in die
vaartbelyning van ons institusionele SIDS ondersoek protokol, asook in die
ontwikkeling van ’n gestandaardiseerde nasionale SIDS ondersoek protokol.
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A scientist in his laboratory is not a mere technician: he is also a child confronting
natural phenomena that impress him as though they were fairytales.
Marie Curie (1867 – 1934)
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Chapter One
1. INTRODUCTION AND LITERATURE REVIEW
1.1 Introduction
Sudden Unexpected Death in Infancy (SUDI) is the collective term for cases where
an infant, younger than one year, dies suddenly and unexpectedly (Weber et al.,
2008). Similarly, Sudden Infant Death Syndrome (SIDS) (also termed “cot death”) is
defined as the sudden, unexplained death of an infant younger than one year old
(Bajanowski et al., 2007; Krous et al., 2004), where no other cause of death can be
confirmed. SIDS is essentially the unexplained death of a clinically healthy infant,
where the cause could not be identified by forensic autopsy and investigation
(including an investigation into the scene and circumstances surrounding the death).
Therefore, SIDS is a diagnosis of exclusion after elimination of other causes and the
validity is dependent upon the accuracy and completeness of the investigations
(therefore, by implication a non-diagnosis). In industrialised countries so-called
SIDS is the leading cause of death in children between one month and one year of
age (Byard & Marshall, 2007).
Autopsies are performed on all SUDI cases and if post-mortem examination and
special laboratory investigations still cannot determine a cause of death, the case is
regarded as SIDS. It is therefore of utmost importance to note the clear distinction
between SUDI and SIDS, even though the terms are used interchangeably and quite
often still confused (Figure 1.1). For the purposes of this study the terms SUDI and
SIDS will be used as per definition stated above, unless counterintuitive usage of the
term is entrenched in the body of research. In these cases, the usage of the term will
be explained in the text.
.
Figure 1.1: The difference between SUDI and SIDS
SUDI
No other
diagnosis
Other
causes of
death
Viral infection
(CMV/Adeno/RSV), etc
SIDS
Investigation
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Viral infection is considered a possible cause or contributory cause of death in cases
of SUDI since an infection that is normally asymptomatic in a healthy adult can cause
severe morbidity in an infant. No standardised infant death protocol exists in South
Africa, but at the Tygerberg Medico-legal Laboratory in the Western Cape Province
all SUDI cases are routinely investigated for the presence of three different viruses,
i.e. cytomegalovirus (CMV), adenovirus and respiratory syncytial virus (RSV). The
routine diagnostic method for these viruses is the South African National
Accreditation Services (SANAS) accredited shell vial culture method. However, a
retrospective audit of SUDI cases over a period of three years (2004 – 2006) revealed
that in only 13.9% of these cases one of these viruses could be identified with the
shell vial method. Since no other cause of death was found in the other 86.1%, these
negative cases were classified as SIDS. We therefore hypothesise that more sensitive
methods, such as immunohistochemistry (IHC) or real-time Polymerase Chain
Reaction (PCR), will be better suited than shell vial cultures to detect viral infections.
1.2 Literature Review
An overview of the history of SIDS (including SUDI) is presented in this section,
including possible causes, viruses that might be implicated, as well as different
methods of viral detection.
1.2.1 History of SIDS1
The history of SIDS can be traced back to Biblical times where infant suffocation was
mentioned in 1 Kings 3 in the Old Testament and this was linked by Pope Stephen V,
who died in 891 AD, to babies sleeping with their mothers at night (Högberg &
Bergström, 2000). This is currently known as bed-sharing or co-sleeping. A Pubmed
search (NCBI database) with keywords “SIDS”, “SUDI”, “cot death” and
“unexpected infant death” also revealed articles from as early as 1918 with SIDS as
main concern.
1 Usage of the term SIDS or cot death in ancient times also includes the entity of SUDI, as formal
investigation into these cases is a relatively recent phenomenon
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1.2.2 Possible causes of SIDS
1.2.2.1 Genetic Factors
SIDS might have a genetic link. Extensive research had been done to investigate
whether the infants who die suddenly and without apparent cause, might be
genetically predisposed to this syndrome. A three-hit model (also known as the triple-
risk hypothesis) has been proposed specifically for SIDS cases (Opdal & Rognum,
2004) and is presented as Figure 1.2. The model includes:
• The infant is at a vulnerable stage in its development (i.e. younger than 1 year)
• Endogenous factors that can contribute to SIDS are present (e.g. genetic factors)
• The process is triggered by an exogenous factor (e.g. viral infection etc.)
Figure 1.2: The proposed three-hit or triple risk model for SIDS. Infants that
succumb to SIDS would fall in the central overlapping area.
The genetic link to SIDS has been divided into two groups. It can either be a mutation
that leads to the death of the child or a polymorphism that gives the child a
disadvantage when confronted with a lethal situation (Opdal & Rognum, 2004), such
as a viral infection. In the latter scenario it would mean that the genetic mutation
Age
Exogenous
Factor
Endogenous
Factor
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together with the presence of a lethal situation would lead to the death of the child.
Should the child also be younger than one year of age, the three-hit model theory
would be applicable.
Genetic alterations in the genome can include fatty acid metabolism, glucose
metabolism, long QT syndrome and thrombosis. Gene polymorphisms, including
HLD-DR, the serotonin transporter gene, C4, IL-10, mitochondrial-
Deoxyribonucleic acid (mt-DNA) and thermal regulation, can also lead to death
under certain circumstances (Opdal & Rognum, 2004). Further research in this field
is vital to understand the connection between genetic make-up and SIDS.
1.2.2.2 SIDS and Bacteria
It is possible that a bacterial infection might cause the release of toxins that can cause
death in an infant, such as those of Clostridium botulinum which can lead to
respiratory paralysis. Other bacteria have been associated with SIDS cases, such as
Escherichia coli, Staphylococcus aureus and Clostridium perfringens (Highet, 2008;
Morris, 1999). Toxins excreted by S.aureus and E.coli can interact with each other
and these toxins have been proven to be lethal in gnotobiotic weanling rat models
(Morris, 1999).
Whether smoking by one or both parents of an infant contributes to the possibility of
SIDS is still a controversial issue. Some scientists believe smoking increases
susceptibility to SIDS (Mitchell, 2009; Sayers et al., 1995; Scragg et al., 1993) and
others believe there is no correlation (Farooqi et al., 1994). However, the combination
of bacterial toxins together with low doses of nicotine proved lethal in chick embryo
models (Morris 1999; Sayers et al., 1995) and even though animal models and
humans cannot always be readily compared, this is surely cause for concern of
whether the combination could also be harmful in human infants.
1.2.2.3 Seasonal Influences
Sudden infant death, across the world, seems to be more prevalent in cooler climates
or winter months (Highet, 2008). Even in a country such as Hawaii, where the average
temperature between winter and summer months is not significantly different; this has
been evident (Mage, 2004). However, a study by Leach et al. (1999) showed more
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SIDS cases being reported in spring. Since the geographic areas, and thus the
climates, of different studies differ, this finding is not seen as unusual.
Sweden has one of the lowest incidences of SIDS worldwide; one death in every 1000
live births in the 1970s – 1980s and even less in the 1990s (Högberg & Bergström,
2000). This country doesn’t experience the change in SIDS rates between their winter
and summer months. A possible explanation for this can be the national maternity
leave programme used in Sweden. This programme allows mothers to stay home and
look after their newborn babies for a year after birth (Samuals, 2003). This decrease in
SIDS cases might be because mothers can then directly monitor their babies
themselves compared to caregivers who have multiple babies and children to look
after.
1.2.2.4 Other factors contributing to SIDS
Maternal alcohol abuse during the time of conception and throughout pregnancy is
seen as a major risk factor for sudden death in infants (Iyasu et al., 2002). Not only
does it lower the unborn infant’s ability to fight infections after birth, but it has also
been suggested to suppress and alter serotonergic receptor binding in areas of the
brain related to cardiorespiratory control. Nicotine, a toxin found in cigarette smoke,
also binds to specific receptors in the brain and alters their normal functioning
(Duncan et al., 2008). All these factors might also play a part in infant death.
The inhalation of cigarette smoke may increase the risk of SIDS. Tobacco smoke
contains a number of toxins which impairs the functioning of the pulmonary system
which can lead to respiratory infections. Smoke has also been proven to diminish the
capability of the killing of bacteria in the lungs of mice. One of these harmful toxins
found in smoke is acrolein. This toxic substance causes dyspnoea in experimental
animals and decreases the capability of the lungs to act against infections (Astry &
Jakab, 1983). According to Samuals (2003), the smoking by one of the infant’s
parents can increase the risk of SIDS by more than 60%. Multiple risk factors are
shared by susceptibility to SIDS and respiratory infections; these include smoking,
socio-economic circumstances, gender, birth-weight and prematurity, as well as ethnic
origin (Blackwell et al., 2004; Samuals, 2003).
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Cytokines can also play a role in SIDS. Raza and Blackwell (1999) proposed that
certain cytokines associated with infection, such as interleukin 1, interferon and
tumour necrosis factor K, can cause somnolence (a severe form of drowsiness) and
hypoxia in extreme cases, which can ultimately lead to death. Both these conditions
have previously been associated with sudden death in infants (Raza & Blackwell,
1999).
1.2.2.5 SIDS and Viral Infection
Respiratory viruses are important factors in SIDS and are often found in the upper and
lower respiratory tract in the autopsies of such cases (Bajanowski et al. 2007). A viral
infection can trigger a genetic polymorphism that causes death or can interact with
bacterial toxins to have a devastating effect (Highet, 2008). Different viral respiratory
infections have been implicated as possible triggers for SIDS, with RSV, influenza B,
parainfluenza 2, rhinovirus, CMV and adenovirus being the most prevalent (Highet,
2008; Samuals, 2003). Viral infections might not always directly cause mortality in
this population group; however, the mere presence could aggravate existing pathology
and contribute to death.
The fact that the incidence of SIDS is significantly higher in winter months and cooler
climates further strengthens the hypothesis that viruses are possible causative agents,
due to their higher prevalence in cooler climates (Highet, 2008; Mage, 2004).
Both Deoxyribonucleic acid (DNA) and Ribonucleic Acid (RNA) viruses have been
implicated in the unexpected deaths of infants, including human herpesvirus (HHV)-
1 and 2 or herpes simplex svirus (HSV), HHV-3 or varicella zoster virus (VZV),
HHV-4 or Epstein-Barr virus (EBV), HHV-5 or CMV, other HHVs (e.g. HHV-6),
RSV, enterovirus, influenza and parainfluenza viruses and adenovirus (Álvarez-
Lafuente et al., 2008; Bajanowski et al., 2003; Dettmeyer et al., 2008; Fernández-
Rodríguez et al., 2006 Raza & Blackwell, 1999; Quan et al., 2000; Weber, 2010).
Although it is not specifically mentioned to be implicated in SUDI, it can well be
suspected that Human Immunodeficiency Virus (HIV) also plays a role in infant
death. HIV is a retrovirus that is integrated into the human genome and being HIV
positive can increase one’s chances of getting secondary viral infections since this
virus causes a deficiency in the human immune system. There is, however, no
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published research to prove or disprove this. All infants born to HIV infected mothers
and who are included in the Prevention of Mother-to-Child Transmission (PMTCT)
programme receive HIV prophylaxis and at 6 weeks, an HIV test is performed (South
African National AIDS Council, 2010). Should a baby be HIV positive and dies
unexpectedly, this leads to an important question of whether this infant should be
regarded as a SUDI case, since HIV infection could very likely be the cause of death.
The impact of viral infection, including HIV infection, in SUDI therefore warrants
further investigation.
The routine protocol for virus detection in SUDI cases at Tygerberg Hospital in the
Western Cape Province, South Africa, is the shell vial culture method for CMV,
adenovirus and RSV. A positive result on any of these tests will not necessarily
conclude that the specific viral infection was the cause of death (Bajanowski et al.,
2007), but in such cases the viral infection could possibly be a contributing factor to
death. A positive result on shell vials also has to be correlated with the macroscopic
autopsy findings and H&E staining before confirming it as official cause of death.
A discussion of the viruses implicated in SUDI with an in-depth discussion of CMV,
adenovirus and RSV follows:
1.2.2.5.1 HHVs
HSV, VZV, EBV, CMV are all HHVs belonging to the Herpesviridae family in the
order Herpesvirales which have been mentioned to possibly being involved in SIDS
(Forsgren & Klapper, 2009).
These viruses all have latent periods in their lifecycles and it is therefore important to
understand the concept of latency as well as the reactivation of a latent virus in
comparison to an acute or chronic infection:
• Latency refers to the ability of a virus to remain dormant in the host cell. This
is typically referred to as the lysogenic stage. HHVs infect their host and
establish and maintain a latent infection, which will be present for the
remainder of the individual’s life (Forsgren & Klapper, 2009). During this
period, only a small number of genes are expressed and even though
replication can still occur at low levels, the expression of certain proteins (such
 10
as the immediate-early/α-proteins in HSV) is absent. During this phase, no
virions can be detected and no viral antigen is expressed in the infected cell.
Since no antigen is present, the immune system of the host cannot recognise
infection and therefore cannot respond to the infection (Forsgren & Klapper,
2009).
• Reactivation refers to periods where viral proteins are expressed and where the
virus replicates. This is also referred to as the lytic stage. During this time the
host can infect other individuals. Since HHVs cause lifelong infection,
reactivation can occur frequently after the primary infection. Triggers for
reactivation of a latent virus can include a number of stimuli, including stress,
sunlight as well as hormone imbalances (Forsgren & Klapper, 2009).
• An acute infection has a rapid onset with a short duration. Since viruses with a
latent cycle present a lifelong infection, an acute infection should not be
confused with a latent viral infection.
• A chronic infection refers to an infection with a slow onset and long-lasting
disease. In this type of infection, infectious particles will be present throughout
the duration of infection.
HSV 1 and 2, also known as HHV-1 and 2, are viruses commonly associated with
oro-facial herpes and genital herpes and primary infection thereof is mostly
through close contact with someone shedding the virus (HSV-1) or through sexual
activity (HSV-2). HSV-2 infection of infants is rare, but not unheard of. Most
infants are protected by maternal antibodies against HSV, but should primary
infection of infants occur, it can easily be overlooked and symptoms can be
thought to be due to ‘teething’. Although most infections are mild or
asymptomatic, recurring HSV infection may cause herpes labialis/fever blisters or
recurring genital vesicles. Severe HSV disease is however seen in infants with
congenital deficiencies in cell mediated immunity (Forsgren & Klapper, 2009).
Since normally HSV infection is easy to misdiagnose in infants, its possible role
in SUDI should be investigated.
‘Chicken pox’ or varicella and ‘shingles’ or herpes zoster are both well-known
diseases caused by VZV infection with chicken pox being from a primary infection
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and shingles from reactivation of the virus. VZV is classified as a common childhood
disease and in most cases, treatment is not necessary. However, complications can
arise and specifically infants are at high risk if the mother is infected with VZV one
week prior to or after giving birth, the infant is born prematurely or weighs less than 1
kg at birth with no maternal antibodies. Infants are often protected by maternal
antibodies, which leave them vulnerable to future infection in life, but then infection
is usually mild and non-life threatening (Breuer, 2009).
EBV is a member of the subfamily Gammaherpesvirinae and is associated with many
different diseases and tumours. In developing countries, EBV has infected 90% of
children by the age of two years. Although most often seroconversion occurs without
any symptoms, a primary infection with EBV later in life results in infectious
mononucleosis, a disease which is common in adolescents (Haque & Crawford,
2009). EBV has been indentified in different SUDI cases (Álvarez-Lafuente et al.2008).
Other HHVs, such as HHV-6, has been suggested as possibly being involved in SUDI
(Álvarez-Lafuente et al.2008). HHV-6 and 7, also known as roseoloviruses, are
members of the subfamily Betaherpesvirinae. HHV-6 infections typically cause a rash
on the neck and trunk but some cases can present only with a fever, without any other
symptoms (Ward & Clark, 2009).
Some of these HHVs (e.g. EBV, HHV-6), have also been detected in SUDI cases with
mild myocardial inflammatory infiltrates (Krous et al., 2009), leading to the question
of what role myocarditis play in SIDS cases.
1.2.2.5.2 Enterovirus
There are a wide variety of enteroviruses, with more than 60 different serotypes and
many potential new serotypes. Although these members of the Picornaviridae family
mostly reside in the gastrointestinal tract it can cause severe illness by spreading to
other organs (Minor & Muir, 2009).
Myocarditis has been accepted as a well-known cause of death in cases originally
thought to be either unexplained or attributed to SIDS (Dettmeyer et al., 2004; Weber
et al., 2010) and it has been suggested that viral myocarditis is more prevalent in cases
of SIDS that is generally accepted (Bajanowski et al., 2003). A major threat for
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neonates is specifically enteroviral myocarditis, because this can lead to death within
two to five days after infection. Coxsackie B virus is the most common enteroviral
cause of myocarditis (Minor & Muir, 2009).
The question of how big a part enteroviruses and specifically enteroviral myocarditis
play in SIDS remains to be answered.
1.2.2.5.3 Influenza
Influenza is well-known due to the yearly epidemics and occasional pandemics it
causes. There are three influenza viruses namely A, B and C and these fall under the
genus Influenzavirus in the Orthomyxoviridae family. Influenza A is primarily viruses
of avian species whilst B and C are human viruses (Zambon & Potter, 2009).
Most societies experience a yearly influenza epidemic, generally at times of high
humidity, which causes severe respiratory illness. It is this frequent outbreak of the
virus that raises questions about its possible involvement in SUDI especially since
cases diagnosed as SIDS have been found to have interstitial pneumonia due to
influenza infection (Bajanowski et al., 2003) raising questions about what was the
true cause of death.
1.2.2.5.4 Parainfluenza
The parainfluenza viruses are members of the Paramyxoviridae family and the
Paramyxovirinae subfamily. There are four serotypes of parainfluenza and infection
causes both upper and lower respiratory tract infections with complications such as
pneumonia and bronchiolitis especially in children. Especially parainfluenza type 3,
which has infected nearly 50% of infants in the first year of life, has been proved to
cause bronchiolotis in infants and to be the most common cause of the hospitalisation
of infants due to respiratory infection (Parrott et al., 1962; Psarras et al., 2009).
Even though parainfluenza infection is not as frequently included in SUDI research as
other viruses, such as CMV and RSV, its involvement should still be considered in
theses cases, especially since it can cause severe illness in infants.
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1.2.2.5.5 CMV
Globally, CMV is regarded to be one of the most frequent congenital infections. It is
also regarded as one of the most successful human parasites and one of the most
commonly encountered viral pathogens in newborn infants (Griffiths 2009; Schleiss,
2006). CMV is a double stranded DNA virus, belonging to the Herpesviridae family
and is also known as HHV-5 (Mans et al., 2009) which, like its family members,
causes lifelong infection (Cannon et al., 2010).
Close contact is the most common mode of transmission for CMV and it can easily be
spread from child to child, child to parent, or parent to child. CMV can also be
transmitted in utero by a mother to her unborn child, leading to congenital CMV in
the baby (Luck & Sharland, 2009). It can also be transmitted perinatally (during
delivery) or postnatally (via breastfeeding) (Griffiths, 2009; Luck & Sharland, 2009;
Schleiss, 2006). It has been estimated that between 40% and 100% of teenagers will
already be infected with CMV by the age of 16 (Griffiths, 2009; Cannon et al., 2010).
CMV is regarded as a relatively common virus with low morbidity, because it remains
asymptomatic in a large proportion of the general population (Luck & Sharland, 2009;
Cannon et al., 2010). Immunocompromised individuals however, such as organ
transplant recipients or patients living with HIV/AIDS, can become severely ill from a
CMV infection. Premature infants and neonates with low birth weight are also
regarded as being immunocompromised (Luck & Sharland, 2009), because of their
underdeveloped immune system, and CMV can cause a variety of complications in
these infants, leading to severe morbidity (Hsu et al., 2001) and even mortality. CMV
is furthermore a risk factor for pregnant women, since this can lead to congenital
CMV of the infant. Peri- and postnatal infections of CMV are usually non-life-
threatening mild infections, but CMV is commonly detected in perinatally infected
infants who develop pneumonitis in the first three months of life. (Griffiths, 2009).
CMV has been mentioned multiple times to possibly being involved in SIDS and
forms part of many studies surrounding SUDI.
A variety of methods for the direct detection of CMV are available, including cell
culture, EM, IHC, tissue fluorescence and PCR methods. Indirect methods can also be
used to detect infection, by measuring an immune response from an individual, rather
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than testing for the presence of the virus. This includes serology and enzyme immuno-
assays (Griffiths, 2009).
There are however a number of problems with the detection of CMV in infants and to
determine whether a positive result is clinically significant. Serological tests might
detect maternal antibodies, giving false information regarding the infant’s immune
status by detecting maternal antibodies instead of the infant’s own, and PCR methods
might not be very specific in their prediction of disease.
One more concern is the following: CMV is also highly prevalent in general in infants
without pathological effect (Álvarez-Lafuente et al.2008). This leads to the question
whether CMV is then actually involved in SIDS and if so, why many infants who are
indeed positive, do not die. A possible explanation might be the triple-risk model
discussed earlier, but further research in this instance is therefore warranted.
1.2.2.5.6 Adenovirus
Adenovirus was first discovered in the early 1950s and 51 other species of
adenovirus have since been described (Echavarría, 2009; Jones et al., 2007). These
non-enveloped, double-stranded DNA viruses, belonging to the Adenoviridae family
and the Mastadenovirus genus, have been classified into 6 species: Human
adenovirus A to F, which can cause a whole variety of illnesses (Jones et al., 2007;
Echavarría, 2009; Hayashi & Hogg, 2007).
Adenovirus infections are common throughout the year and have a worldwide
distribution. It can be transmitted faeco-orally, through water, fomites or by means
of aerosols (Echavarría, 2009).
Adenovirus infection, in comparison with a HHV infection, causes an acute infection
instead of a lifelong infection. Infection by different species of virus results in
different types of disease in humans, including gastroenteritis, pharyngitis,
pneumonia, keratoconjunctivitis and acute respiratory disease (Brodzinski & Ruddy,
2009; Hayashi & Hogg, 2007; Jones et al., 2007). Adenovirus is one of the leading
causes (along with Rhinovirus, RSV and Influenza) of pneumonia (Figueiredo, 2009;
Marcos et al., 2009) and children younger than 5 years of age are more susceptible to
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adenovirus infection, which often develops into pneumonia (Hayashi & Hogg,
2007).
A variety of diagnostic methods can be used for the direct and indirect detection
(detection of an antibody rather than an antigen) of adenoviruses, including cell
cultures, IHC, EM and PCR (direct), as well as serology (indirect) (Echavarría,
2009). Since no latent period is present in this virus’s life cycle, similar problems to
CMV (and other HHVs) with the detection of the virus is not present and positive
diagnostic results can be attributed to primary infection.
1.2.2.5.7 RSV
RSV is a single-stranded RNA virus that belongs to the Paramyxoviridae family
along with human metapneumo- and parainfluenza viruses and falls under the
Pneumovirus genus (Figueiredo, 2009; Ogra, 2004; Olson & Varga, 2008). It was
discovered in chimpanzees in 1956 and is divided into two major strains, namely RSV
A and RSV B (Figueiredo, 2009; Ogra, 2004). These two strains infect approximately
50% of children in their first year of life and by the age of two, most children have
been infected already (Vicencio, 2010). Acute respiratory disease in children caused
by RSV is the most common cause of hospitalisation and is regarded as the leading
cause of morbidity and mortality in children worldwide (Hoffman et al., 2004; Hall,
2009).
RSV has a worldwide distribution and causes annual seasonal outbreaks in different
parts of the world. Although it is more prevalent in winter months, countries with
warmer or tropical climates can experience the presence of RSV throughout the year
(Hall, 2009). Transmission of RSV occurs mainly through fomites and aerosols which
enter the eyes or nose, whereafter it spreads to the lower respiratory tract (Hall, 2009).
Nosocomial transmission of RSV is quite common, especially since infection
generally causes mild infection in adults and symptoms are not severe enough to
require an absence from work. Therefore, infected healthcare workers can easily
spread RSV to already vulnerable children in clinic and hospital settings (Hall, 2009).
Primary infection with RSV can cause pneumonia and bronchiolitis and is often
associated with wheezing (Hall, 2009; Ogra, 2004). Although RSV infection is not
normally life-threatening, it can cause severe morbidity and mortality in
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immunocompromised patients (Ogra, 2004; Olson & Varga, 2008) and therefore RSV
is a huge concern in infants. Research into the effect of RSV in SUDI cases is thus
justified.
Since nosocomial transmission can cause large outbreaks in susceptible children, RSV
infection should be diagnosed as soon as possible to prevent further spread of the
virus. Rapid tests are available for quick diagnosis, but a variety of other laboratory
tests also exist to be utilised in RSV diagnosis, such as viral isolation, serology and
molecular methods. RSV, like adenovirus, has no latent period and therefore a
positive diagnostic test can be interpreted as a primary infection.
1.2.3 SIDS Epidemiology
SIDS and SUDI is a worldwide phenomenon and although lower incidences are seen
in some countries, no geographical area is overlooked.There are a number of different
factors influencing susceptibility to SIDS. Leach et al. (1999) summarised this as
follows: prematurity, male gender, low birth weight and age, which was also
mentioned previously. The different seasons of the year might also play an important
role in SIDS and SUDI. In the same study by Leach et al. (1999), most SIDS cases
were reported in spring whereas most SUDI cases, with a known cause of death after
investigation, were observed in autumn. Other studies have shown that SIDS has a
higher prevalence in winter months (Highet, 2008).
Kinney and Thach (2009) reported that black infants in the USA and infants of mixed
ancestry in South Africa are at higher risk of SIDS than others. Kitsantas and Gaffney
(2010) suggested a possible reason for this being that mothers who are at high risk of
post neonatal deaths of their babies often do not have access to high risk neonatal and
obstetric services. They also propose that the education of new mothers would be
instrumental in the lowering of the amount of SIDS cases in these high risk groups.
1.2.4 Diagnosis in SUDI
A thorough death scene investigation and complete autopsy are required in all cases of
SUDI. This should involve different diagnostic approaches, including, but not limited
to, microbiology, virology and complete histology of all the organs (Arnestad et al.,
2002; Bajanowski et al., 2007). A positive result in any of these fields does not
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necessarily automatically indicate a cause of death, since the finding might not be
severe enough to explain death (Highet, 2008) and the decision of when an infection
or condition is serious enough to cause death, remains controversial (Arnestad et al.,
2002; Samuals, 2003).
Common causes of death in forensic investigation of SUDI cases include infections,
accidental and non-accidental death, as well as congenital malformations (Arnestad et
al., 2002; Weber et al., 2008). Infections, especially pneumonia, seem to be the most
prominent cause of death after full autopsy in the literature (Arnestad et al., 2002;
Loughrey et al., 2005; Prtak et al., 2010; Weber et al., 2008). If the method of
detection, however, is not sensitive enough to detect all true positives, many possible
infections could in fact be missed, resulting in cases being wrongly classified as SIDS.
Different diagnostic approaches have been followed in the literature for the
investigation of SUDI. Álvarez-Lafuente and colleagues (2008) used a quantitative
real-time polymerase chain reaction (real-time PCR) to detect three different HHVs
i.e. EBV, CMV and HHV-6 in different types of tissue, including lung, brain, kidney
and spleen. Their data showed EBV and HHV-6 to be more prevalent in suspected
SIDS cases than in healthy infants (which consisted of a group of violent deaths and
one case of sudden death due to natural causes where infection was ruled out). They
proposed that SIDS might be caused by the combination of respiratory infections and
environmental factors together with underlying causes, such as a genetic
predisposition (Álvarez-Lafuente et al., 2008).
A different study used PCR in combination with IHC and in-situ hybridization to
investigate 121 cases of SIDS. Lung tissue from all five lobes as well as a sample
from the salivary gland was used and a total of three positive cases, confirmed by
one or more of the abovementioned methods, for the presence of CMV were found
(Dettmeyer et al., 2008).
Another research group used IHC and PCR to investigate two SIDS cases and was
able to confirm adenovirus, by means of PCR, in the intrabronchial fluid of a 5-
month-old infant. The authors noted that infants around this age are more susceptible
to infections due to an underdeveloped or immature defence response against
pathogens. This immunological inability to eradicate pathogens can ultimately lead
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to sudden death in an infant, whereas the same pathogen would cause only mild
illness in older children and adults (Quan et al., 2000).
PCR, serology, cell cultures and electron microscopy (EM) were used by a different
group to investigate samples from 64 autopsies for the presence of viruses. Samples
used include different tissue types (lung, brain, kidney, liver etc.), cerebrospinal fluid
(CSF) and bodily fluids (nasal washings, respiratory fluids etc.). These tests were
used to confirm the presence of influenza A and B, adenovirus, RSV, VZV, HSV,
EBV, HHV-6 and CMV. Positive results were found for adenovirus, influenza A,
EBV, CMV, HHV-6 and RSV. The authors noted that traditional microbiological
approaches cannot always be readily applied to forensic samples. Tissue autolysis
starts occurring immediately after death which compromises cell structure and
nucleic acids (Fernández-Rodríguez et al., 2006).
These studies all confirm that cultures, PCR and IHC are suitable methods for the
detection of specific viruses (Álvarez-Lafuente et al., 2008; Dettmeyer et al., 2008;
Fernández-Rodríguez et al., 2006). A benefit of PCR compared to the other methods
is the ability to utilise small tissue samples, which is often the case in autopsies of
SUDI cases.
Histology can also be employed to investigate respiratory infections in autopsy lung
tissue. Bajanowski et al. (2003) used histology on autopsy lung tissue from 105
SIDS cases, followed by PCR in cases where specific RNA viruses (RSV, influenza
A, influenza B and parainfluenza) were confirmed. Adenovirus was the most
frequent respiratory infection in these cases (25% compared to 8.5% for Influenza B
and 12% for CMV) (Bajanowski et al., 2003).
However, isolating viruses from the lung tissue from SIDS cases has proven to be
difficult: Sample size often poses the biggest problem (Quan et al., 2000). By
definition, SIDS infants are younger than 1 year and therefore have very small lungs,
resulting in very small samples being available for analyses. Furthermore, samples are
usually formalin-fixed after the autopsy, which compromises the quality and integrity
of the nucleic acids present in the tissue (Álvarez-Lafuente et al., 2008). There is
often a time delay of up to seven days between death and autopsy, which could be
attributed to different circumstances, including distance from the deceased’s home or
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place of death to the mortuary, especially in rural areas. Shortages of forensic
pathologists or other problems, such as disasters leading to many autopsies and
causing backlogs can also result in delays. These time delays can further influence the
quality of nucleic acids vital for viral detection.
Other pitfalls specific to post-mortem samples exist, such as low viral loads that can
negatively influence both cell culture results and EM findings. It is also unclear
whether a viral infection with a low viral load is capable of causing death but when
seen in conjunction with other factors, such as secondary infections, malnutrition etc.
it might be worthwhile considering the infection as a possible cause of death. It is
therefore of utmost importance in forensic pathology to find a reliable diagnostic
method that can overcome these problems. Molecular techniques, such as PCR, can
improve the the detection and identification of viral infections for as long as the
nucleic acid is intact. This is unlike cell culture methods, where post mortem
organism overgrowth, which can include organisms such as α haemolytic
streptococci, Staphylococcus epidermidis and Escherichia coli (Prtak et al., 2010),
can interfere with the detection of viruses, and EM, where autolysis steps in shortly
following death and compromises the integrity of cells. Real-time PCR can further
add benefit to the diagnosis by quantifying viral load.
Positive PCR results should be carefully interpreted especially in the case of HIV,
HHVs (such as CMV) and other infections which might have latent periods. These
organisms have periods where there is not an active infection in the body even though
the virus is still present, although dormant. These infections are therefore chronic/long
lasting. The viral particles then remain dormant until they are reactivated. However,
PCR can be used extensively for non-HHVs, such as adenovirus, RSV and
parainfluenza since these viruses do not have latent periods (Fernández-Rodríguez et
al., 2006).
Obtaining fresh samples directly from each autopsy, processing it immediately to
preserve nucleic acid integrity and using methods such as real-time PCR might
alleviate problems associated with post mortem tissue to some extent.
The methods used in this study will be discussed in section 1.2.5 and its applications
in SUDI cases in section 1.2.6.
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1.2.5 Methods of viral detection
1.2.5.1 Cell culture Methods
Cell cultures have long been regarded as the gold standard in the detection of
respiratory viruses (Ieven, 2007; Leland & Ginocchio, 2007). These methods have the
ability to demonstrate the viability of a virus and positive results are mostly linked to
active infections. Qualitative molecular techniques and antigen detection assays will
only give positive results even if the infection in question is latent (Leland &
Ginocchio, 2007).
Shell vial cultures, where a cell monolayer is grown on a coverslip in a small vial into
which the test specimen is inoculated, have become a popular derivative of
conventional cell culture methods. Shell vials take up less space than normal culture
tubes and this method is quicker and cheaper than, but still as sensitive as
conventional cell cultures (McAdams & Riley, 2009). There is however evidence that
shell vial cultures are not as sensitive as conventional cultures specifically in the case
of CMV detection (Erice et al., 1992; Mazulli et al., 1993; Pedneault et al., 1996).
1.2.5.2 Conventional and Real-time PCR
The conventional PCR was first described by Kary Mullis in 1983 (Van Guilder et al.,
2008) with real-time PCR, a modern molecular technique that is becoming
increasingly popular, stemming from the original conventional PCR. Real-time PCR
is regarded as an improvement on conventional PCR, producing either qualitative or
quantitative results, whilst conventional PCR only provides qualitative information.
PCR is based on the principle of amplifying the target nucleic acid (DNA or RNA)
and detecting the product by means of either gel-electrophoresis at the end of the
assay (conventional PCR) or a fluorescent dye, which is cleaved off when the probe
binds to the target sequence. This omits a signal after being cleaved and can be
visualised in real-time (real-time PCR). These methods are useful diagnostic tools for
the detections of highly pathogenic pathogens as well as cases where viruses do not
proliferate in normal cell cultures, such as hepatitis B and C, and parvovirus B-19. It
is also a much faster method than conventional culture methods (Leland & Ginocchio,
2007; Tregoning & Schwarze, 2010).
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A major disadvantage of real-time PCR is the high cost of the test (Addendum D) but
this can be alleviated by using multiplex PCR reactions i.e. test for the presence of
multiple viruses with one PCR reaction. Another disadvantage is the inability of the
test to differentiate between an active and latent viral infection (Leland & Ginocchio,
2007) unless a viral load test is performed (by using the real-time PCR quantitatively).
This can mean that the test is too sensitive for clinical use and that results may not be
clinically relevant (Griffiths, 2009; Machida et al., 2000). However, quantitative PCR
gives information about the viral load of an infection, and that information can be
used to distinguish between active and latent infections.
1.2.5.3 H&E
H&E staining is used routinely to investigate histological changes in tissues and is
widely used for medical diagnoses and is routinely used in medico-legal
investigations. These stains are used to differentiate between the cell nucleus (stained
by haematoxylin) and the cytoplasm (stained by eosin) in tissues.
This method allows significant changes in tissues to be seen (Wittekind, 2003) in a
relative inexpensive manner. A disadvantage of this method is its inability to
distinguish between different infections and additional tests are required to confirm
suspected infections (Bajanowski et al., 2007). It is, however, a very valuable test in
determining whether a positive infection is indeed significant. If no changes in the
lung are present but a virological test is positive, the infection will not be considered
as being fatal.
1.2.5.4 IHC
IHC is based on the principle that an antibody, which is bound to a reporter enzyme or
fluorescent dye, can be bound to its corresponding antigen whereafter it can be
visualised under a light microscope. A diagnosis can then be made according to the
distribution of inclusion bodies in tissue and cells, as well as the tissue structure (i.e.
whether inflammation and other structural changes are present). (Haines & West,
2005; Linnoila & Petrusz, 1984).
There are two types of antibodies used in IHC, monoclonal and polyclonal antibodies,
and IHC can be used on fresh and unfixed tissue, but formalin-fixed, paraffin-
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embedded (FFPE) tissue is most commonly used. Antigen retrieval is an important
step in the IHC process, since fixation causes the antigenicity of the tissue to be
masked by reversible cross-linkages of protein amino acid residues by methylene
bridges, rendering the antigen invisible (D’Amico et al., 2008; Shi et al., 2001;
Sompuram et al., 2004). This results in the inability of the specific antibody to bind to
the antigen, leading to incorrect results, such as false negatives. The amount of cross-
linking in the tissue can be controlled by fixation time, fixative pH and concentration
of the fixative (D’Amico et al., 2008). Antigen retrieval breaks these cross-linkages
and can be performed in a variety of ways, including heat (Heat-induced epitope
retrieval or HIER) and enzyme-based methods, radiation by means of a microwave or
by boiling the tissue sections (D’Amico et al., 2008; Sompuram et al., 2004).
IHC is also an expensive method (Addendum E) and even though it can confirm the
presence of specific antigen in the tissue, it cannot quantify the infection (Goyal et al.,
2008). Only small quantities of tissue is needed (Leake, 2000), but if this specific
piece of tissue does not contain the antigen in question, a false negative result can
occur. Interpretation and reporting of results can often be subjective (Leake, 2000)
and care should be taken to differentiate between background staining and true
positive results. Factors, such as differences in antigen retrieval times, makes
standardising IHC difficult, but this can be overcome by adopting a standard protocol
for the processing of all types of tissue before staining (Leake, 2000).
1.2.5.5 Electron Microscopy
The electron microscope can magnify images up to one million times and enables
scientists to see viruses, which are too small to see with a light microscope. Since
morphological differences between viruses are visible by means of electron
microscopy, this technique plays a very important role in the classification of viruses.
A number of new viruses have been described with the aid of EM, including Hendra
and Nipah (Henipa) viruses (Goldsmith & Miller, 2009).
No target specific reagent is required to visualise a pathogen by EM. It provides an
‘open view’ of whatever is present in the test sample (Goldsmith & Miller, 2009;
Jeffery & Aarons, 2009) and allows the ultra structure of viruses and other pathogens
to be seen. EM can show the presence of all viruses, even those that cannot be
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cultured or are highly pathogenic, and it is also a rapid technique, yielding results
within a day (Jeffery & Aarons, 2009).
This highly technical process requires a highly trained technician and EM tests are
very expensive. Even though all viruses can be detected by EM, a high viral load is
required, since EM has a low sensitivity. Approximately 1 million viral particles per
millilitre of fluid / tissue culture supernatant are needed for a positive result (Jeffery &
Aarons, 2009) and therefore a low positive might be portrayed as being negative.
Thus, EM has limited diagnostic applications. Although there is doubt about the
future of this method due to its shortcomings (Jeffery & Aarons, 2009) EM currently
remains the only direct visualisation method for viruses and other pathogens and EM
is of vital importance in the discovery and diagnoses of newly emerging pathogens.
These attributes will keep this method of viral detection alive, even if not for
diagnostic purposes, then certainly for research applications.
1.2.6 Application of methods in SUDI
1.2.6.1 Cell Culture Methods
Cell culture methods, which include shell vial cultures, are used routinely in cases of
suspected SUDI but recently it is being replaced by PCR technology in certain SUDI
cases, especially cases of suspected myocarditis (Bajanowski et al., 2007; Krous et
al., 2009; Lozinski et al., 1994).
As mentioned earlier, there is evidence that shell vials are not as sensitive for the
detection of CMV (Erice et al., 1992; Mazulli et al., 1993; Pedneault et al., 1996) and
it should be kept in mind that CMV is a labile virus (Espy & Smith, 1987), a serious
cause for concern in post-mortem tissue. The time delay between death and post
mortem examination could therefore already influence the results seen on shell vials.
Any further delay between post mortem examination and the diagnostic test can also
increase degradation of the virus leaving no live virus in the tissue sample, leading to
false negative results.
1.2.6.2 Conventional and Real-time PCR
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PCR methods are very popular because of its high sensitivity and specificity and
mostly because of its rapidness. However, there are a number of problems with these
methods in the detection of some viruses in SUDI cases.
As discussed previously, HHVs (and specifically CMV in the case of this study) have
latent periods where no active infection is present and although PCR methods are
highly sensitive and specific for the detection of CMV, a positive result should be
carefully interpreted. Because of the latent period and periodic reactivation of CMV, a
positive PCR result might be the result of a primary infection, a latent virus or a
reactivated virus (Bhatia et al., 2010). It should, however, be kept in mind that SUDI
cases are defined to be less than one year of age. Therefore a positive PCR result will
likely be because a primary infection instead of a reactivated virus. Also the effect of
CMV on certain infants, specifically those with low birth weight etc., as discussed in
1.2.2.5.5, is more severe than on older individuals. A primary infection might
therefore be more cause of concern that would have been in another patient.
The same concern with post-mortem detection of CMV as mentioned in section
1.2.6.1 i.e. degradation of nucleic acid, is a factor and negative results may be
apparent in cases where there was actually indeed a CMV infection.
All these concerns highlight the fact that no diagnostic method is flawless and careful
interpretation of both positive and negative results are of utmost importance.
1.2.6.3 H&E
H&E stains are routinely used and mandatory in the investigation surrounding death
of SUDI cases. Specifically, histology of the respiratory tract is very important
because of the significance of respiratory infections in SUDI (Bajanowski et al.,
2007). Although H&E stains are very useful in cases of suspected infection, this
method on its own as diagnostic method is not very specific as it shows changes due
to infection, but different infections cannot always be distinguished.
Certain histological changes are very common in SUDI cases. These include
congestion, mild oedema etc. and are non-specific changes (Bajanowski et al., 2007)
not necessarily related to death. However, an infection might aggravate these changes
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and therefore virological investigations are suggested to correlate with histological
changes (Bajanowski et al., 2007; Fernández-Rodríguez et al., 2006).
At the Tygerberg Medico-legal facility the routine protocol is exactly this, to correlate
virological investigations with the histology seen on H&E stains.
1.2.6.4 IHC
Even though IHC investigations in SUDI cases are not mandatory, it is recommended
in some cases to enhance the diagnoses of certain cases and to distinguish between
pathology and non-specific changes in the lungs (Bajanowski et al., 2007).
Even though the method is highly specific due to specific antibodies used, background
staining can interfere with detection, leading to inaccurate results. Also, the tissue
used for IHC purposes is relatively small due to the size of the infants involved and
should the antigen not be present in this sample, negative results can lead to an
incorrect interpretation of the case.
1.2.6.5 Electron Microscopy
EM is often used in the investigation of SIDS and SUDI cases and has been used
successfully in the detection of viral infections (Fernández-Rodríguez et al., 2006;
Weber et al., 2010)
However, EM specifically in the investigation of SUDI cases has a much lower yield
than other diagnostic tests (Weber et al., 2010) and the quality of post-mortem tissue
is not always suitable for EM purposes ((Fernández-Rodríguez et al., 2006). This is
due to the fact that autolysis of cells begins shortly after death, and therefore it is very
difficult to distinguish between potential pathogens and cell debris, especially if one
considers the magnification that is involved in EM. Also, EM requires a high viral
load in order to detect an infection and low viral loads will therefore go by unnoticed,
giving a negative result ((Fernández-Rodríguez et al., 2006).
Thus, although a very classic method of detecting viruses, EM might not be entirely
suitable for the detection of viruses in SUDI cases.
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It is thus clear that not one method is perfect in the diagnosis of a SUDI case. A
possible solution could be a combination of different methods, but further research
into which methods are best for the detection of specific viruses is therefore vital.
1.3 Aim of this study
Preliminary data from Tygerberg hospital shows a mere 14% positive yield on the
current standard testing protocol for viral infections in SUDI cases and investigation
into alternative and better suited diagnostic methods seems therefore justified. In this
study we will attempt to improve the diagnosis of possible viral infections in SUDI
cases. The current medico-legal protocol tests routinely for CMV, adenovirus and
RSV with the shell vial culture method and we hypothesise that this method is not
best in confirming the presence of specific viruses as more modern techniques, such
as real-time PCR and / or IHC. If this hypothesis can be confirmed, it will result in a
more better diagnosis of SUDI cases and a decreased number of SIDS cases (where
no other diagnosis can be confirmed).
To date, no such research, which compares different methods in SUDI cases, has been
conducted in South Africa, where socio-economic and environmental conditions are
significantly different from those in developed countries.
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Chapter Two
2. MATERIALS AND METHODS
2.1 Introduction
The study was conducted as two components. First, a retrospective data audit was
conducted to determine the virological yield of cases. This was followed by the
prospective analysis of post mortem samples from 82 babies which were obtained
from the Tygerberg Mortuary. This chapter outlines three different diagnostic
methods that were used to test these samples for the presence of three different
respiratory viruses.
2.2 Ethics Approval
The project was approved by the Health Research Ethics Committee of Stellenbosch
University on 22 June 2009 and extended for another year on 21 April 2010. Waiver
of individual consent for the additional laboratory tests was applied for on the basis
that the study material collected, as well as tests performed, do not differ from the
protocol currently in use at the Tygerberg Medico-legal Mortuary. Waiver was
granted. The ethics reference number for this study is N09/02/046 (Addendum A).
2.3 Retrospective Audit
A retrospective audit was performed by examining the SUDI case files from 2004 –
2006 to determine in how many of these cases positive results for viral infection could
be obtained.
2.4 Study Population and Sample Collection
The study population included 82 infants, male and female, less than one year old
(with the exception of only one case which was 14 months old but fit all the other
criteria) that fit the criteria of SUDI/possible SIDS. Infants that had a known cause of
death were excluded. All study infants died unexpectedly in their sleep.
The seasonal distribution of death was classified using the published article of Leach
et al., (1999) as a guideline:
• Summer: December - February
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• Autumn: March - May
• Winter: June - August
• Spring: September - November
Samples were obtained from the post mortem examinations of these cases. The left
lower lobe (LLL) of the lung was excised (this is the routine lung lobe used for
virological and microbiological tests) and placed into a sterile container, which was
transported to the Division of Forensic Pathology, 6th floor, Clinical Building,
Tygerberg Campus in a sterile, sealed pathology sample bag. Samples were collected
from 29 September until 27 May 2010. The chain of custody was maintained at all
times.
The mean post mortem interval (time between death and post mortem examination)
was 3.4 ± 2 days, ranging between 0 days (autopsy done on the same day as death)
and 8 days.
2.5 Sample Processing
All samples were weighed and this information was sent to the attending pathologist
to be recorded on the official post mortem report. The mass of the lung lobes ranged
between 7 g and 52 grams (g). The complete results are indicated in Addendum B.
Forceps were flamed for at least 25 seconds over a Bunsen burner prior to use to
ensure sterility. Hereafter the sample was placed on a sterile Petri dish (94 mm x 16
mm, triple vent) (Greiner, Austria) for dissection. A sterile surgical blade (Number
23, Fitment No.4) (Paramount Surgimed, Germany) and 4L scalpel handle were used
to cut the sample in half and one of the pieces (sample A) was then placed in 10%
formalin. Cassettes were marked with the sample number (samples were
consecutively numbered in order of collection), the reversed ethics number, as well as
“LLL”, which indicated the sample was from the lower lobe, left lung. The reversed
ethics number was used to ensure samples can be easily identified and has no other
significant meaning. A typical example of the number would therefore be “001-
N046/02/09 LLL”. After a minimum of 24 hours the formalin-fixed samples were
trimmed to fit inside the corresponding, standard histology cassettes, which were then
processed to prepare formalin-fixed wax blocks for histology purposes.
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The other half of the original sample (sample B) was subdivided to be used for the
different tests. One piece of approximately 3x1x1 mm was excised from sample B and
placed in a 2.0 ml eppendorf tube (Axygen Scientific, USA), containing 2 ml 2.5%
gluteraldehyde (Sigma Aldrich, USA). This was stored at 4°C for EM purposes.
Gluteraldehyde is the preservative of choice for EM, since it preserves the tissue
better than formalin would and it is routinely used and preferred by the Division of
Anatomical Pathology’s EM technicians.
Another piece of the lung was removed from sample B for routine shell vial cultures.
A 5x5x5mm piece of lung was excised (also from sample B) and placed in 2 ml
eppendorf tube containing 1.5 ml Viral Transport Medium (VTM) (Highveld
Scientific, SA) for transport to Virology Specimen Reception, 8th Floor, Clinical
Building, Tygerberg Campus. VTM is used to preserve the virus(es) for shell vial
cultures and contains antibiotics to prevent bacterial overgrowth and contamination of
the sample.
Two further small pieces of sample B were excised for Real-time PCR purposes. One
was placed in VTM until DNA extraction, while the other was placed in RNALater
(Sigma Aldrich, USA) for RNA extractions. This was done to ensure the nucleic acid
stays intact and does not denature before extraction. Both samples were kept at 4ºC
until further processing.
The remaining lung tissue was then placed in the original container, covered with
between 2 and 15 ml VTM, depending on the size of the remaining tissue, and frozen
at -80°C.
2.6 Shell Vial Cultures
2.6.1 Subculture of Cells
All cells were subcultured according to the routine SANAS accredited method.
Human Fibroblasts (HF) were used for CMV and combination (combi) cultures
containing both HEp2 and Madin-Darby Canine Kidney (MDCK) cells for adenovirus
and RSV.
1X Active Trypsin Versine (ATV) (Sigma Aldrich, USA) was prepared by using
90 ml milliQ water (MilliQ™ Water System, Millipore, Ireland) and 10 ml 10XATV.
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Culture medium was decanted and discarded from the culture flask and 1XATV (pre-
warmed in waterbath to 37ºC) was added to cover the monolayer of cells. The flask
was rinsed to remove excess foetal calf serum (FCS) (Sigma Aldrich, USA) to prevent
trypsin inactivation caused by FCS. The ATV was decanted and 10 ml fresh, warmed
1XATV was added again. The flasks were then incubated for 5 – 10 minutes at room
temperature, whereafter the contents was transferred to centrifuge tubes and
centrifuged in a Centaur 2, Sanyo centrifuge for 5 minutes at 1000 revolutions per
minute (rpm). The supernatant fluid was discarded and the pellet resuspended in
medium by pipetting. Growth medium was added up to 30 ml.
A cell count was done using a Neubauer counting chamber (Figure 2.1) and cells were
prepared at a concentration of 15 x 104 cells/ml. These cell cultures were then
transferred to shell vials and incubated at 37ºC for 48 hours, until a monolayer of cells
was formed.
1 mm
corner
square
Figure 2.1: Neubauer Counting Chamber. All the live cells in any 3 large blocks
(containing 16 small blocks) are counted and then the amount of
cells/ml can be calculated using the formula below (figures obtained
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from Thomas Scientific, USA and Montreal Biotechnologies Inc.,
Canada)
In order to determine the number of cells per millilitre, cells were diluted in 10 ml
media. A small volume of cells (20 microlitre (µl)) and 20µl trypan blue were then
mixed and placed onto a Neubauer Counting Chamber. Non-viable cells, e.g. where
the cell membrane has been damaged, absorb the trypan blue and distinguish it from
viable or live cells, which do not stain.
The amount of cells in three different blocks (Figure 2.1) was then counted and the
following formula (Biowhittaker, Biotechnology Products Catalog and Technology
Manual, 1993) was used to determine the number of cells/ml (Appendix C).
Total cells/ml = total cells in all counted squares x 10^4* x 2**
number of counted squares
*10^4 = volume conversion factor to 1 ml
**2 = specific dilution factor (trypan blue)
2.6.2 Shell vials
Upon receipt, each lung sample was placed in an autoclaved mortar and 2 ml VTM
and 0.2 ml antibiotic cocktail were added to the tissue. A small amount of ground
glass was used to assist in breaking the tissue and this mixture was then grinded
thoroughly with a pestle to create a homogenous suspension.
Another 6 ml of VTM was added to the mixture which was transferred to a labelled
15 ml centrifuge tube and centrifuged at 2000 rpm for 10 minutes at 4ºC in a
Beckman GPR centrifuge. After centrifugation the specimen was filtered through a
0.20 µm filter with a 10 ml syringe and inoculated into a labelled shell vial.
CMV and adenovirus shell vials were incubated for 48 hours at 37ºC, which is the
normal human body temperature and thus the optimal temperature for normal human
pathogens. Combi cultures were incubated for 48 hours at 33ºC since respiratory
viruses that are present in the upper respiratory tract, which is cooler than the normal
human body temperature, replicate better at this temperature (Message & Johnston,
2004; Papadopoulos et al., 2009).
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2.6.3 Immunofluorescence Assay (IFA)
IFA staining was done using a LIGHT DIAGNOSTICS™ Respiratory Panel 1 Viral
Screening & Identification IFA Kit (Millipore, USA). The protocol in the
manufacturer’s kit was followed. The cell nucleus in CMV infection is green, while
adenovirus infection will display a green cytoplasm. The respiratory virus combi
respiratory panel includes screening for parainfluenza 1 – 3, influenza A and B,
adenovirus, RSV and human metapneumovirus. All the infected cells will be stained,
which means that one or more of the aforementioned viruses is positive. Retesting for
individual viruses using the same method must then be done to identify the virus.
Shell vials are considered positive if more than 5 cells are stained; if less than 5, but
more than 1 cell is positive, the test is repeated.
2.7 Real-time PCR
For this method, nucleic acid extraction must be performed after which the PCR is set
up and run on a suitable PCR platform.
2.7.1 DNA Extraction
A QIAamp® DNA Mini Kit (Qiagen, Germany), containing QIAamp Mini Spin
Columns, 2 ml Collection Tubes, Buffer AL, Buffer AW1, Buffer AW2, Buffer AE,
Buffer ATL and Proteinase K, was used for DNA extractions. Buffer ATL are used
with the Proteinase K as tissue lysis buffer, where the Proteinase K causes the
denaturing of proteins present in the tissue. Buffer AL is a further lysis buffer and
Buffer AW1 and AW are wash buffers used to remove impurities. Buffer AE is the
elution buffer, used in the final step of the procedure to elute the DNA. Ethanol and
RNase A were also used during the extraction to optimise binding conditions and to
ensure that RNA-free genomic DNA is obtained. The DNA extraction procedure is
based on the principle that DNA is adsorbed to the silica-gel membrane in the QIAmp
Mini spin column during centrifugation; which can then be eluted after purification to
yield purified DNA.
After cleaning all work surfaces with freshly prepared biocide to remove potential
pathogens and 70% ethanol to remove the the corrosive effect of biocide, DNA
extraction was performed using the manufacturer’s protocol for DNA purification
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from tissues. Tissue lysis was complete in 1 – 3 hours; this was evident when no
tissue could be seen in the sample tube. .
The eluted DNA was then stored at -20°C until further use (QIAamp® DNA Mini and
Blood Mini Handbook, 2007).
2.7.2 RNA Extraction
A QIAShredder™ Kit (Qiagen, Germany), containing QIAShredder Spin Columns,
and an RNeasy® Mini Kit (Qiagen, Germany), containing RNeasy® Mini Spin
Columns, Collection Tubes, Buffer RLT, Buffer RW1, Buffer RPE and RNase-free
water were used for RNA extractions. Buffer RLT contains guanidine-thiocyanate and
is used as denaturing buffer, ensuring pure, intact RNA. Buffer RW1 and RPE are
wash buffers used to remove any impurities and contaminants from the RNA. Finally,
RNase-free water is used for the elution of the extracted RNA. Ethanol is also used
during the procedure to ensure optimal binding conditions. This technology is based
on the binding of RNA to the RNeasy® silica membrane in the RNeasy® Mini spin
column and combined with the speed of centrifugation, ultimately leading to the
extraction of RNase-free RNA.
After cleaning all work surfaces DNA extraction was performed using the
manufacturer’s protocol for Purification of Total RNA from Animal Tissues, using
protocol 3b (”Disruption using a mortar and pestle followed by homogenization using
aQIAshredder homogenizer”).
The eluted RNA was stored at -80ºC until further use (RNeasy® Mini Handbook,
2006).
2.7.3 DNA and RNA Concentrations
Concentrations of DNA and RNA nucleic acids were measured on a Nanodrop
Spectrophotometer (Nanodrop Technologies, USA). Nuclease-free water, 1 µl, was
used to blank the system whereafter the same volume of either DNA or RNA was
added. The appropriate action was taken (i.e. DNA-50 or RNA-40) to measure the
nucleic acid concentration and the concentration (nanogram (ng)/µl) was noted. The
complete results can be found in Addendum C.
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2.7.4 Primer and Probe Design
Although primers and probes in this study were obtained from previously published
papers, primers and probes can be also designed by using a variety of online and
commercially available programs. The following processes are involved in the
designing of primers and probes:
• Collection of gene sequences of target organism. Genebank can be used for this
purpose.
• Alignment of sequences with ClustalX version 1.81 or similar programs.
• Manually finding a consensus sequence using Geneious version 4.3 software.
• Choosing primer target sequences in highly conserved region. Probe sequence is
then chosen and fluorescent dyes are selected based on the wavelength that must be
used e.g. FAM for green channel, VIC for yellow channel etc. Quencher dyes must
be compatible with the fluorescent dye, e.g. FAM with TAMRA etc.
• It is also important to ensure that the melting temperatures of forward and reverse
primers are not too far apart, otherwise primers will not be able to attach to the
target sequence properly.
2.7.5 Real-time PCR Setup
Positive controls for the different assays were obtained from the Quality Control for
Molecular Diagnostics (QCMD) programme. This programme is an international
External Quality Assessment (EQA) organisation which aids in monitoring the quality
of molecular tests in clinical laboratories. All real-time PCR tests were initially run
for 45 cycles according to the original protocols. Because low positives can easily be
mistaken for negative samples, the cycles were increased to 50 to ensure that low
positives could also be detected. The fluorescent dyes used are visualised in different
channels. FAM is detected in the green channel at wavelength 510 nanometer (nm),
while VIC is detected in the yellow channel at wavelength When a multiplex PCR is
used, as in the case of the RSV assay published by Kuypers et al. (2004), two
different fluorescent dyes are used to ensure that they do not overlap and that both
target sequences are detected.
Real-time PCR results were interpreted qualitatively. Both the other methods, shell
vial cultures and IHC, only provide qualitative results and therefore the quantification
of the real-time PCR results would not contribute to the comparison of the methods.
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Although qualitative real-time PCR can be used in the same manner as conventional
PCR, real-time PCR was used because this is a modern method with the ability to
quantify results which, although not used specifically in this study due to other
methods not having the same ability, could be provide valuable information to the
pathologist regarding viral loads etc. Therefore real-time PCR was chosen out of a
prospective point of view.
2.7.5.1 CMV & Adenovirus PCR Optimisation
Published primer and probe sequences were used for real-time PCR assays. All
primers and probes were ordered from Applied Biosystems. Sequences were obtained
from the published articles by Preiser et al. (2003) and Heim et al. (2003) for CMV
and adenovirus respectively (Table 2.1). Sequences were BLASTed (NCBI, Pubmed)
to ensure they were correct and targeted genes of the target organism.
CMV primers and probe were designed to target a conserved region in the UL89 gene
which codes for the DNA terminal packaging subunit 1 and amplifies a fragment of
approximately 140 base pairs (bp) (Preiser et al., 2003). The adenovirus PCR primers
and probe was designed to target highly conserved regions in the hexon gene to detect
all 51 types of the human adenovirus (Heim et al., 2003). These primers were
designed after aligning genomes from five fully sequenced human adenoviruses i.e.
type 2, type 5, type 17 and type 40. By aligning the primers with reference adenovirus
genomes on Genbank, the amplicon size was determined to also be approximately 140
bp long.
CMV and adenovirus probes were provided in a lyophilised pellet at 50 nmol and
primers at 130 nmol. Probes were reconstituted by adding of nuclease-free water
(Qiagen, Germany) to both probes to make up a stock solution of 1 millimolar (mM)
for each.
Table 2.1: Primer and probe sequences for the detection of CMV and
Adenovirus (Preiser et al., 2003; Heim et al., 2003).
Virus Sequence (5' - 3')
CMV
Forward Primer CGT-TGG-TGT-TGT-AGC-AAG-TGG-C
Reverse Primer TGT-GCT-CAA-AGA-GGT-CGA-GTT-CC
Probe VIC-CGC-GAA-GGT-GTG-TGG-CGG-CAG-TAMRA
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Adenovirus
Forward Primer GCC-ACG-GTG-GGG-TTT-CTA-AAC-TT
Reverse Primer GCC-CCA-GTG-GTC-TTA-CAT-GCA-CAT-C
Probe
FAM-TGC-ACC-AGA-CCC-GGG-CTC-AGG-TAC-TCC-
GA-TAMRA
Aliquots of the stock solution were made and then diluted with nuclease-free water to
create a working concentration of 10 µM. The primer stock solutions were prepared in
the same manner for all primers and 10 µM working concentrations were prepared.
This was done to prevent multiple freeze-thaw cycles of the working solution, as this
can reduce the fluorescent signal strength and damage the primers/probe. A final
concentration of 10 µM was used to ensure that volumes are not too small to pipette
accurately.
Preiser et al. (2003) published optimal concentrations of the primers and probes in
each real-time PCR reaction for CMV, which was 300 nanomolar (nM) for forward-
and reverse primers, as well as the probe. The same concentrations were first tested
using positive controls and later used in this study.
Heim et al. (2003) reported using final concentrations of 0.5 millimolar (mM) (each
primer) and 0.4 mM (probe) for adenovirus. These concentrations seemed extremely
high and likely to be a printing error. To avoid non-specific binding of the primers
and the wasting of expensive reagents, the concentrations were adjusted to 500nM for
each primer and 400 nM for the probe before the first real-time PCR run. The adjusted
values were tested using positive controls and confirmed to be correct.
A real-time PCR mastermix was prepared for each virus (Table 2.2 for CMV and 2.3
for adenovirus) using a Sensimix™ Probe Kit buffer (Bioline, Germany) and
nuclease-free water. The purpose of the mastermix was to eliminate pipetting and
other systematic errors by working with one large volume instead of multiple smaller
volumes. A fixed volume of 20 µl of the mastermix could then be transferred to 0.2
ml Thin Wall PCR® tubes (QSP, California, USA) and 5 µl of known positive nucleic
acid (positive control) or nuclease-free water (non-template control) was added to
each reaction in a separate room to eliminate contamination of primers/probes and
buffer with nucleic acid. Two non-template controls were included in each run where
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nuclease-free water was used instead of nucleic acid. Tubes were placed in the Rotor-
Gene 6000 (Corbett life science, Australia) real-time PCR platform and conditions
were set for the specific viruses. These conditions are described in Tables 2.4 (CMV)
and 2.5 (adenovirus).
Table 2.2: Mastermix setup for CMV real-time PCR
Reagent Concentration(µM)
Concentration
(µM)
µl per 1
reaction
Working solution Final
2 x uMM Buffer 2 x 1 x 12.50
FP (forward primer) 10 300 0.75
RP (reverse primer) 10 300 0.75
P (probe) 10 300 0.75
water 5.25
Template 5.00
total volume µl 25.00
Table 2.3: Mastermix setup for adenovirus real-time PCR
Reagent Concentration(µM)
Concentration
(µM)
µl per 1
reaction
Working solution Final
2 x uMM Buffer 2 x 1 x 12.50
FP (forward primer) 10 500 1.25
RP (reverse primer) 10 500 1.25
P (probe) 10 400 1.00
water 4.00
Template 5.00
total volume µl 25.00
Table 2.4: Cycling conditions for CMV in the Rotor-Gene 8000.
Cycles Time Temperature (ºC)
2 min 50
10 min 95
50x 10 sec 9545 sec 60
Table 2.5: Cycling conditions for adenovirus in the Rotor-Gene 8000.
Cycles Time Temperature (ºC)
5 min 35
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10 min 95
50x 3 sec 9510 sec 55
After optimisation with positive controls, all samples were tested in duplicate and
where inconclusive results were found, a third real-time PCR assay was performed.
2.7.5.2 RSV PCR Optimisation
The RSV real-time PCR was initially done according to the method published by
Kuypers et al. (2004). The sequences can be found in Table 2.6. However, this assay
did not work correctly and the method according to Watzinger et al., (2004) was
rather used.
The RSV primers and probes in the Kuypers et al. (2004) method were designed to
target the RSV polymerase gene from both RSV A and RSV B, amplifying a 94 bp
fragment whilst the Watzinger et al. (2004) method was designed to target specifically
the N gene of the virus for the amplification of a 149 bp fragment (Watzinger et al.,
2004).
Both forward and reverse primers (for Kuypers et al., (2004) method) were
manufactured by Applied Biosystems and supplied in a lyophilised pellet form. These
were reconstituted and a working solution of 10 µM was prepared. Two probes were
used for this assay by Kuypers et al., (2004) for the two different subtypes, one FAM-
labelled probe for RSV type A and another VIC-labelled probe for RSV type B.
Different fluorescent dyes are used to differentiate between the two virus types.
The final concentration of the primers and probes in the reaction were also obtained
from Kuypers et al. (2004) and 250 nM for both primers and 100 nM for both probes
were used. A mastermix was prepared (Table 2.7), using a Sensimix™ Probe One-
Step Kit (Bioline, Germany) and nuclease-free water (Qiagen, Germany). A final
volume of 40 µl in each PCR tube contained 30 µl mastermix and 10 µl positive
control or nuclease-free water, for the non-template control (NTC).
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Table 2.6: Published primer and probe sequences for the detection of RSV.
Virus / Publisher Sequence (5' - 3')
RSV / Kuypers et al.,
2004
Forward Primer AAT-ACA-GCC-AAA-TCT-AAC-CAA-CTT-TAC-A
Reverse Primer GCC-AAG-GAA-GCA-TGC-AAT-AAA
Probe A FAM-TGC-TAT-TGT-GCA-CTA-AAG-MGBNFQ
Probe B
VIC-CAC-TAT-TCC-TTA-CTA-AAG-ATG-TC-
MGBNFQ
RSV / Watzinger et al.,
2004
Forward Primer GGC-AGT-AGA-GTT-GAA-GG
Reverse Primer ACA-ACT-TGT-TCC-ATT-TCT-GC
Probe
FAM-ACT-TGC-CCT-GCA-CCA-TAG-GCA-TTC-
ATA-AAC-AAT-TAMRA
Table 2.7: Mastermix setup for RSV Real-time PCR (Kuypers et al., 2004).
Reagent Concentration(µM)
Concentration
(µM)
µl per 1
reaction
Working solution Final
2 x uM Buffer 2 x 1 x 20.00
FP forward primer 10 250 1.00
RP reverse primer 10 250 1.00
P probe A 10 100 0.40
P probe B 10 100 0.40
template 10.00
water 7.20
total volume µl 40.00
The PCR tubes were placed in the Rotor-Gene 6000 real-time PCR machine and
conditions were set for the specific viruses (Table 2.8.)
Table 2.8: Cycling conditions for RSV real-time PCR (Kuypers et al., 2004)
Author Cycles Time Temperature (ºC)
Kuypers et al., 2004 5 min 35
10 min 95
50x
3 sec 95
10 sec 55
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However, this assay did not work correctly (Figure 2.3) and negative results were
obtained when the assay was tested with positive controls. Concentrations were
therefore adjusted by means of a checkerboard titration with concentrations 300, 600
and 900 nM for primers and 200, 400 and 500 nM for the probes. The same reaction
was also run on the ABI-7900 real-time PCR machine (Applied Biosystems,
Germany) in an attempt to identify the problem. After multiple runs, it was concluded
that the probes were damaged.
Figure 2.2: RSV real-time PCR – Kuypers et al. (2004). This real-time PCR was
run according to the method of Kuypers et al. (2004) with positive
controls, but did not work properly.
Another set of primers and a probe were obtained from Integrated DNA Technologies
from the published sequence by Watzinger et al. (2004) (Table 2.6). These were
reconstituted to a working concentration of 10 µM in the case of the primers and
40 µM for the probe. After confirming that concentrations used in the published
article was correct by performing PCR runs with positive control for this purpose, the
final concentrations of the forward primer, reverse primer and probe in each reaction
were 900 nM, 300 nM and 200 nM respectively. A mastermix was set up (Table 2.9)
and 19 µl of mastermix and 6 µl of known positive template were mixed in a PCR
tube. Two non-template controls were added in each run where nuclease-free water
was used instead of nucleic acid. This was placed on the Rotor-Gene 6000 with the
cycling conditions in Table 2.10.
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Table 2.9: Mastermix setup for RSV Real-time PCR (Watzinger et al., 2004).
Reagent ConcentrationµM
Concentration
µM µl per 1 rxn
Stock Final
2 x uMM Buffer 2 x 1 x 12.50
FP forward primer 10 900 2.25
RP reverse primer 10 300 0.75
P probe 40 200 0.13
template 6.00
water 3.38
total volume µl 25.00
Table 2.10: Cycling conditions for RSV real-time PCR (Watzinger et al., 2004)
Author Cycles Time Temperature (ºC)
Watzinger et al., 2004 5 min 35
10 min 95
50x
3 sec 95
10 sec 55
After optimisation, all samples were tested in duplicate and where inconclusive results
were found, a third real-time PCR assay was performed.
2.8 Histology
2.8.1 Processing of tissue for histological examination
Tissue was fixed in formalin for at least 24 hours. Thereafter, it was trimmed into
smaller pieces and put into histological cassettes as described under sections 2.5
(Sample Processing). The preparation of the wax blocks was done in a Tissue Tek
VIP 5 Tissue Processor, which uses a graded series of ethanol, starting at 70% and
ending with 100%. This was used to dehydrate the tissue, i.e. remove all water and
fixative from the tissue. The dehydration fluid was replaced with xylene (Merck,
Germany) by soaking the section in two changes of concentrated xylene, whereafter it
was impregnated with paraffin wax (Paraplast Plus) (Merck, Germany) and embedded
into a wax block manually.
Slides were prepared with the corresponding sample numbers and the wax blocks
were cut into 3-5 µ sections on a MICROM Rotary microtome (Thermo Scientific,
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Germany). These sections were floated out on a waterbath at 45ºC to prevent fold and
cracks in the sections. Each section was mounted on positively charged Superfrost
Plus slides (Thermo Scientific, Germany). The slides were then placed at 65°C for at
least 20 minutes to ensure binding of the section to the slide and to melt all excess
wax.
2.8.2 H&E Staining
H&E staining was done manually. Formalin pigment on these slides was not removed,
since removal of the pigment is not routinely done. Slides were used also for routine
medico-legal purposes and the standard protocol was therefore adhered to.
Slides were taken from the incubator and immediately immersed in xylene for 5
minutes. This was done to remove paraffin wax to ensure that the slide contents are
mixable with water, since the dyes used are water-soluble. This process was repeated
three times. It was then placed in decreasing concentrations of ethanol, starting with
three changes 100% ethanol (Sigma Aldrich, USA) for 5 minutes each, followed by
96% and then 70% ethanol, each for 5 minutes. The slides were then placed in normal
tap water at room temperature for 5 minutes to wash off all remaining ethanol,
whereafter it was submerged in Mayers-Haematoxylin (Merck, Germany) for 5
minutes. This was rinsed with running tap water for 5 minutes and placed in 2.5%
Eosin (Merck, Germany) for 1 minute, whereafter it was washed with running tap
water again. The slides were subjected to rising concentrations of ethanol, starting
with 5 minutes in 70% followed by 5 minutes in 96% and ending with 5 minutes in
three changes of 100% ethanol. The final step was to transfer the slides to xylene, this
was done in three changes for 5 minutes each to ensure proper washing and prevent
carry-over of the ethanol. Coverslides were mounted on the slides with a resinous
mounting media (DPX) (Merck, Germany). The slides were left for a few hours to dry
at room temperature.
2.8.3 Optimisation
Optimisation and testing were done on the Leica BOND-MAX™ automated system
(Leica Microsystems), using a Bond™ Polymer Refine Detection System. Positive
controls were used for optimisation and included in each test batch of ten slides (nine
tests and one control). A CMV positive control was obtained from Mrs Rochelle van
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Wijk, Southern Cross Biotechnologies. Adenovirus and RSV controls were donated
by Mr Ronald Houston, Anatomical Pathology Manager of Childlab, a Division of
Nationwide Children’s Hospital, USA.
Overfixation of some samples occurred due to prolonged storage in formalin. This
resulted in the factory settings for antigen retrieval and staining not being used.
Processes were therefore adjusted whereafter it was optimised. Formalin pigment,
which is commonly found in post mortem tissue and is associated with overfixation
due to prolonged periods in formalin, had to be removed on all slides. This was done
using a picric acid (Merck, Germany) treatment and is described in section 2.8.4. All
IHC slides, even those without formalin pigment, were subjected to this treatment
prior to staining to ensure uniformity of the IHC process.
Heat-induced Epitope Retrieval (HIER) was used for antigen retrieval. The following
protocols were used in the optimisation: ER-1 20 min; ER-2 20 min; ER-2 30 min and
finally ER-2 40 min at 97ºC using Ethylenediaminetetraacetic Acid (EDTA)/citrate
buffer. Antibodies were tested at a 1:100 and 1:50 dilution and were diluted in Bond
Primary Antibody Diluent. .
The final protocol used for all three antibodies was a primary antibody dilution of
1:50 with an ER-2 40 min at 97ºC antigen retrieval step and an antibody incubation
time of 50 minutes.
2.8.4 Treatment for removal of formalin pigment
Picric acid and absolute ethanol (Sigma Aldrich, USA) were used to remove formalin
pigment, which was present in the tissue.
Slides were placed on a hot plate (60ºC) for 2 minutes to melt all excess wax and then
further de-waxed by placing it in xylene for 5 minutes. They were then transferred to
two changes of xylene, each for 5 minutes. In order to hydrate the tissue, slides were
placed in three changes of 100% ethanol and then transferred to saturated picric acid
to remove the pigment caused by formalin fixation. After 40 minutes, the slides were
rinsed in 90% ethanol for 5 minutes, followed by another 5 minutes in 70% ethanol
for hydration of the tissue. Finally, running tap water was used to wash the slides for
15 minutes before staining.
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2.8.5 IHC Staining
After treating the slides to remove the formalin pigment, it was dried thoroughly with
paper towel. Labels were printed using the BOND-MAX™ software and affixed to
each slide. Every slide had therefore two identification numbers; the original
identification number as described under section 2.5. (Sample Processing) and the
BOND-MAX™ number used by the system to identify the different slides.
After labelling, slides were placed on a slide tray and five drops of Bond Wash Buffer
was added to every slide. A covertile was placed on each slide. The covertile works
through capillary action, spreading fluid evenly across the slide.
The full slide tray, as well as already diluted antibodies (described in Table 2.11), was
then placed in the BOND-MAX™ system. The BOND-MAX™ protocol was
followed for IHC staining with a prolonged antigen retrieval step of 40 minutes at
97ºC. The protocol was set on a computer containing the BOND-MAX™ software
and the process was initiated.
Table 2.11: Antibodies used for IHC staining.
Antibody Supplier Optimised
Retrieval
Retrieval Time
& Temperature
Antibody
dilution
CMV Leica Microsystems HIER ER-2* 40 min @ 97ºC 1:50
RSV Leica Microsystems HIER ER-2 40 min @ 97ºC 1:50
Adenovirus Leica Microsystems HIER ER-2 40 min @ 97ºC 1:50
*Bond Epitope Retrieval Solution 2 (EDTA based, pH 9)
Slides were taken from the BOND-MAX™ system, placed in three changes of 100%
ethanol and transferred to three changes of xylene. Finally slides were placed in a
Tissue-Tek® SCA (Sakwa) automated coverslipper and coverslips were attached to
each slide, using xylene as adhesive.
2.8.6 Grading of H&E stains
All IHC and H&E stains were investigated by two blinded individuals, the primary
researcher and a forensic pathologist.
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Interstitial pneumonitis on H&E stains were graded as follows (for purposes of this
study and in SUDI cases in general, grade 2 or 3 interstitial pneumonitis is seen to be
severe enough to cause death) (Krous et al., 2003):
0. No interstitial pneumonitis present
1. Interstitial pneumonitis is hardly present, focal with no overall alteration of the
alveolar septa
2. Interstitial pneumonitis is relatively diffuse with mild thickening of alveolar
septa
3. Interstitial pneumonitis associated with interstitial oedema, diffuse
involvement.
4. Diffuse infiltration associated with significantly widened alveolar septa.
2.9 Transmission Electron Microscopy
Three positive samples for each one of the viruses (CMV, adenovirus and RSV) and
one negative sample (acting as negative control) were used for EM. Samples were
considered positive if one or more of the aforementioned assays produced positive
results.
2.9.1 Sample Preparation
Processing was done automatically in a Leica EMTP Processor and the protocol for
processing by this manufacturer was followed (Leica Microsystems, Germany).
The processed tissue was then trimmed to an acceptable size to view under a light
microscope after toluidine blue staining: these sections are slightly larger than the
sections used for viewing under the electron microscope. A Resin Block Trimmer
(Leica Microsystems, Germany) was used for this purpose. Slides were cut into 2 µm
blocks using a newly made glass knife, made with a LKG 7800 Knifemaker, in a
Reichert Ultra Microtome (Reichert, Austria). Cut sections were placed on a clean
microscope slide and stained with toluidine blue.
2.9.2 Toluidine Blue Staining
A toluidine blue stain was done on sections of the different tissue to aid in the
detection of possible viruses. The area in the tissue where infection is suspected
should be used for the further processing of the sections used for EM since EM is
directed at such a small target. Failure to use infected tissue will lead to false negative
results and therefore the toluidine blue staining is used to detect areas of possible
infection.
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Slides were placed in sodium methoxid, prepared by dissolving 5 g Sodium in 100 ml
methanol, for 1 minute, followed by two rinses in absolute ethanol (Sigma Aldrich,
USA) to remove excess resin. Running water was used to rinse the slides for 1 minute,
whereafter the sections were covered in toluidine blue and heated with a Bunsen
burner for one minute to ensure proper penetration of the dye in the tissue. Slides
were again rinsed with running water for one minute whereafter they were dried with
filter paper and kept on a hot place (60º) until no water drops were visible. Coverslips
were added to each slide, using DPX mounting media.
The toluidine blue stained slides were then visualised under a dissection microscope
(American Optimal Corporation).
2.9.3 EM
After toluidine blue staining and visualisation of the slides under a light microscope,
the processed tissue was trimmed down further, including areas of suspected
infection, and sections were cut using a new glass knife. The sections were then
placed on a copper mesh grip for viewing by means of a JEM-1011 electron
microscope (JEOL, Japan).
2.10 Statistical Analysis
The statistical analysis for this study was done by Mr Justin Harvey from the Centre
for Statistical Analysis, University of Stellenbosch.
Descriptive statistics were done using STATISTICA 9 and Kappa Statistics were
performed using SAS version 9.1.
2.10.1 Descriptive Statistics
Frequency tables and histograms of the following variables were drawn: ethnicity,
gender, presence of bedsharing, maternal smoking or alcohol use during pregnancy,
prematurity, prone sleeping position, history of illness prior to death, post mortem
interval, as well as histology, IHC, real-time PCR and shell vial results for each
different virus (CMV, adenovirus and RSV). Histograms and frequency tables of
either grade 1 or grade 2/3 interstitial pneumonitis were drawn as well. Results will be
discussed in Chapter 3 and 4.
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When a diagnosis of a grade 2/3 interstitial pneumonitis in the absence of any other
positive findings could be made, this was strongly considered as being the most likely
cause of death. Positivity on any of the three methods (shell vials, real-time PCR or
IHC) was considered an overall positive for the presence of the virus. This positivity
(referred to as ‘mixed positivity’) and the presence of grade 2/3 interstitial
pneumonitis were cross tabulated in a 2-way summary table. The statistics thereof
were calculated using the Pearson Chi-square and Fisher exact two tailed tests. Should
a value of “0” exist the Pearson Chi-square test should not be used as this test is not
considered to be accurate in the statistical analysis of “0”-values. A p-value of less
than 0.05 is considered significant.
2.10.2 Kappa Statistics
The amount of agreement between tests was calculated using Kappa statistics. Results
of every test (shell vials, real-time PCR, IHC, as well as histology) were compared
with that of every other test for each virus. When there is no significant difference
between the tests, the Kappa Coefficient will be high (1 = absolute agreement, 0 = no
agreement). A Pr>S value (p-value) is considered significant (i.e. there is a significant
difference between the two tests) if it is smaller than 0.05.
According to the statistical test there should be a difference in values of at least 10
between the positivity of the two tests being compared for it to be an accurate
presentation of the results.
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Chapter Three
3. RESULTS
3.1 Introduction
A total of 82 samples were tested with three different methods and the results will be
discussed in this chapter.
3.2 Retrospective Audit
The retrospective audit done on all SUDI cases from 2004 – 2006 revealed that only
14% (n = 51) of cases were positive for the presence of CMV, adenovirus and/or RSV
out of a potential 366 cases. These positives included 46 positive CMV cases, six
positive for adenovirus and only one for RSV with two being dual infections (CMV
and adenovirus).
No information regarding demographic distribution of the cases in the retrospective
audit was available to the researcher due to ethical constraints and this information
could therefore not be included in the study.
3.3 Demographics – Prospective Study
The ethnic and gender distribution of the SUDI cases are presented in Figure 3.1.
Figure 3.1(a) and (b): Ethnic and gender composition. As indicated by (a), two
thirds of the total number of infants was black. The ratio
between male and female, as indicated by (b) was more equal,
although there was a slight male predominance.
59%
Male
41%
Female
Male
Female
b
33%
Coloured
66%
Black
1%
White
Black
Coloured
White
a
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The mean age of the infants was 11.6 ± 10.5 weeks (2.9 months) with ages ranging from
When the seasonal distribution of the study population is considered it is important to keep in
mind that sample collection of this study started in September and ended in May, thus
excluding winter. This was done because of time constraints of the study. Ideally such a study
should run over more than one calendar year, to include all different seasons as well as
seasonal infections (i.e. different strains of influenza) and also for comparing of the same
seasons in different years. However, the seasonal distribution of this study included 24% (n =
20) cases of SUDI in spring, 30% (n = 25) cases in summer and 45% (n = 27) in autumn.
3.4 Shell vial cultures
3.4.1 CMV
Results from shell vial cultures identified three positive results for CMV (Figure 3.2),
while the rest of the cultures were all negative. One shell vial culture was
contaminated by bacteria and was discarded.
Figure 3.2(a) and (b): CMV shell vial cultures. Shell vial (a) shows several
fluorescent nuclei, whereas (b) seems mostly negative, but
with 4 fluorescent nuclei, therefore (b) will be repeated to
confirm the result (Photographs provided by Ms Marna
Blomerus, NHLS).
a b
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3.4.2 Adenovirus
None of the shell vials were positive for the presence of adenovirus (Figure 3.3). One
of the shell vials (the same as the case in CMV) was contaminated with bacteria and
was thus discarded.
Figure 3.3: Positive adenovirus on shell vials. An example of a positive
adenovirus shell vial (Photographs provided by Ms Marna Blomerus,
NHLS).
3.4.3 RSV
One combi shell vial result was positive for the presence of a respiratory virus, but the
viral load was too low to determine which specific virus it was.
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Figure 3.4(a) and (b): Positive respiratory virus on combi shell vials. (a)
indicates a high positive and (b) a lower positive
(Photographs provided by Ms Marna Blomerus, NHLS).
3.5 Real-time PCR
The results of the real-time PCR tests are discussed in this section.
3.5.1 DNA and RNA Concentrations
DNA concentrations were between 7.6 ng/µl and 247.6 ng/µl with a mean value of
61.1 ± 49 ng/µl. RNA concentrations were between 8.4 ng/µl and 545.1 ng/µl with a
mean value of 97.3 ± 92 ng/µl. The complete results can be found in Addendum C.
Examples of random DNA and RNA concentrations are shown in Figures 3.5 and 3.6.
a b
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Figure 3.5: DNA concentration. Sample N046/02/09-047.
Figure 3.6: RNA concentration. Sample N046/02/09-018.
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3.5.2 CMV
A total of 29 samples tested positive for CMV on real-time PCR, which was 35% of
the total number of samples. Figure 3.7 is an example of the real-time PCR graph
containing multiple positive results. A threshold was added just above the NTCs to
simplify the process of determining which samples were negative compared to low
positives. Ct-values of positive controls were consistently between cycles 23.30 and
32.39. Sample Ct-values were between cycles 18.54 and 39.27. The colours in which
samples and controls are visualised were chosen at random.
Figure 3.7(a) and (b): Multiple real-time PCR positive results for CMV. Where
the curve exceeds the threshold and has a typical logarithmic
curve. Straight or slightly curved lines toward the x-axis are
a
b
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considered negative. The positive control is visualised in red
(a) and green (b).
3.5.3 Adenovirus
Two samples (014- & 015-N046/02/09) tested positive on real-time PCR for
adenovirus. Ct-values were between cycles 26.88 and 34.51 for positive controls and
at cycles 33.80 and 43.20 for the two positive samples. Figure 3.8 shows the
adenovirus real-time PCR run for three different concentrations of positive controls.
Figure 3.8: Adenovirus real-time PCR – Positive controls. A test run was done
with three concentrations of positive controls to ensure validity of the
PCR. Concentrations were 1:1, 1:10 and 1:100.
3.5.4 RSV
No positive results were found for RSV with the real-time PCR method. The Ct-
values of the positive controls of the runs were between cycle 27.00 and cycle 38.16.
Figure 3.9 shows results obtained from the Watzinger et al. (2004) real-time PCR
method
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Figure 3.9: RSV real-time PCR – Watzinger et al. (2004). All samples tested
negative. The positive controls can be seen in green.
3.6 Histology and IHC
3.6.1 H&E
Interstitial pneumonitis, severe enough to be considered a cause of death (i.e. grade
2 – 3) was present in 15% (n=12) of the cases. Other noteworthy histological changes
can be found in Table 3.1.
Table 3.1: Distribution of histological changes in the LLL.
Histological Condition Percentage n
Congestion 68 56
Oedema 37 30
Collapse 60 49
Alveolar Debris 15 12
Interstitial Alveolar Haemorrhage 18 15
Sloughing of lining epithelium 4 3
Formalin pigment 18 15
PM Organism overgrowth 11 9
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3.6.2 CMV
Two samples were positive on IHC when examined for CMV. Inclusion bodies were
evident in the histology and IHC of these cases (An example of a positive IHC stain
on CMV tissue is shown in Figure 3.10 (a)).
3.6.3 Adenovirus
No samples were positive for adenovirus on IHC. The positive control used in IHC for
adenovirus is shown in Figure 3.10 (b).
3.6.4 RSV
A total of four samples were positive for the presence of RSV on IHC. Figure 3.10 (c)
shows the positive control for RSV on IHC.
a
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Figure 3.10(a), (b) and (c): IHC staining of positive tissues. An example of a
positive CMV IHC stain can be seen in (a). The positive
controls for adenovirus and RSV are shown in (b) and
(c) respectively. (Figures (b) and (c) courtesy of Mr
Ronald Houston, Childlab, Nationwide Children’s
Hospital, OH, USA)
3.7 Comparison of the three methods
Three samples tested positive for CMV with the shell vial method compared to 29
positives on real-time PCR and 2 positives on IHC. Two samples were positive for the
presence of adenovirus by means of real-time PCR testing and four samples revealed
the presence of RSV by means of IHC. These results, plus the presence of a grade 2/3
b
c
 61
interstitial pneumonitis and the medical history (i.e. whether the infant was sick or
displayed symptoms of illness prior to death), are summarised in Table 3.2.
Table 3.2: Grade 2/3 Interstitial Pneumonitis and results of viral detection by
different methods
Sample
Number
Gr2/3 Int
Pneumonitis CMV Adeno RSV Sick prior to death
001-
N046/02/09 No Yes
002-
N046/02/09 Yes Yes
003-
N046/02/09 No SV**/PCR*** No
004-
N046/02/09 No PCR No
005-
N046/02/09 No PCR No
006-
N046/02/09 No PCR No
007-
N046/02/09 No *BC *BC *BC Yes
008-
N046/02/09 No SV/PCR No
009-
N046/02/09 No No
010-
N046/02/09 Yes SV/PCR No
011-
N046/02/09 No Yes
012-
N046/02/09 No No
013-
N046/02/09 No No
014-
N046/02/09 No PCR No
015-
N046/02/09 No PCR Yes
016-
N046/02/09 No No
017-
N046/02/09 No No
018-
N046/02/09 No No
019-
N046/02/09 No No
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Sample
Number
Gr2/3 Int
Pneumonitis CMV Adeno RSV
Sick Prior to
Death
020-
N046/02/09 No No
021-
N046/02/09 No PCR Yes
022-
N046/02/09 No PCR No
023-
N046/02/09 No Yes
024-
N046/02/09 No No
025-
N046/02/09 No PCR Yes
026-
N046/02/09 No No
027-
N046/02/09 No No
028-
N046/02/09 No No
029-
N046/02/09 No No
030-
N046/02/09 Yes PCR Yes
031-
N046/02/09 Yes Yes
032-
N046/02/09 No Yes
033-
N046/02/09 No No
034-
N046/02/09 No No
035-
N046/02/09 No No
036-
N046/02/09 Yes No
037-
N046/02/09 No Yes
038-
N046/02/09 No No
039-
N046/02/09 No No
040-
N046/02/09 No PCR No
041-
N046/02/09 No No
042-
N046/02/09 No No
043-
N046/02/09 Yes PCR Yes
044-
N046/02/09 No No
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Sample
Number
Gr2/3 Int
Pneumonitis CMV Adeno RSV
Sick Prior to
Death
045-
N046/02/09 No PCR No
046-
N046/02/09 No Yes
047-
N046/02/09 No No
048-
N046/02/09 Yes No
049-
N046/02/09 No PCR No
050-
N046/02/09 No Yes
051-
N046/02/09 No No
052-
N046/02/09 No Yes
053-
N046/02/09 Yes PCR IHC Yes
054-
N046/02/09 No IHC No
055-
N046/02/09 No PCR Yes
056-
N046/02/09 No Yes
057-
N046/02/09 No Yes
058-
N046/02/09 Yes IHC No
059-
N046/02/09 No No
060-
N046/02/09 No No
061-
N046/02/09 Yes PCR No
062-
N046/02/09 No PCR No
063-
N046/02/09 No PCR Yes
064-
N046/02/09 No PCR Yes
065-
N046/02/09 No No
066-
N046/02/09 No Yes
067-
N046/02/09 No Yes
068-
N046/02/09 No PCR No
069-
N046/02/09 No No
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Sample
Number
Gr2/3 Int
Pneumonitis CMV Adeno RSV
Sick Prior to
Death
070-
N046/02/09 Yes PCR No
071-
N046/02/09 No PCR No
072-
N046/02/09 No No
073-
N046/02/09 No PCR IHC No
074-
N046/02/09 No No
075-
N046/02/09 No No
076-
N046/02/09 No No
077-
N046/02/09 No No
078-
N046/02/09 No PCR No
079-
N046/02/09 Yes PCR No
080-
N046/02/09 No PCR No
081-
N046/02/09 No PCR No
082-
N046/02/09 No PCR No
* - Bacterial Contamination
**SV – Shell Vials
***PCR – Real-time PCR
3.8 Transmission Electron Microscopy
TEM was performed only on randomly selected positive samples, since this is a very
expensive method, costing approximately R950 per sample. Sample number 003-
N046/02/09 was used for CMV, 014-N046/02/09 for adenovirus (Figure 3.11) and
050-N046/02/09 for RSV. Although the latter sample was confirmed negative on real-
time PCR, it was the only RSV sample to test positive once (once in three tests).
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Figure 3.11: TEM Micrographs for Adenovirus and CMV. Due to autolysis of
the tissue, individual viruses could not be recognised.
3.9 Statistical Analysis
3.9.1 Descriptive Statistics
3.9.1.1 CMV
A total of 7 cases had grade 2 or 3 interstitial pneumonitis and were positive for
CMV. A Pearson chi-squared test resulted in a p-value of 0.06605 and the p-value of a
Fisher exact, two tailed test was 0.09938. An interaction plot of each the 2-way
summary tables were drawn (Figure 3.12). If the two lines intersect, an association is
expected.
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Interaction Plot: CMV x Int Pneumonitis - Gr 2/3
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Figure 3.12: Interaction Plot: CMV x Interstitial Pneumonitis Grade 2/3
3.9.1.2 Adenovirus and RSV
None of the cases had both interstitial pneumonitis and a confirmed adenovirus
infection and only two cases were positive for RSV and had interstitial pneumonitis.
No statistical significance could be found in either the Pearson Chi-squared or the
Fisher exact, two-tailed tests. These results are evident in the interaction plots (Figure
3.13 and 3.14).
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Interaction Plot: Adeno x Int Pneumonitis - Gr 2/3
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Figure 3.13: Interaction Plot: Adenovirus x Interstitial Pneumonitis Grade 2/3
Interaction Plot: RSV x Int Pneumonitis - Gr 2/3
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Figure 3.14: Interaction Plot: RSV x Interstitial Pneumonitis Grade 2/3
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3.9.2 Kappa Statistics
The amount of deviation between methods for adenovirus and RSV was too small to
perform a statistical analysis. There were however significant differences between the
methods for CMV (Table 3.5). Agreement between Histology, IHC and shell vials
were good, but a highly significant was seen against real-time PCR.
Table 3.3: Kappa Coefficient and P-values for method comparison – CMV
CMV Kappa
Coefficient
Pr > S
(p-value) CommentMethodComparison
IHC & Histology 0.6611 0.3173 No significant difference between
methods.
qPCR & Histology 0.0438 < 0.0001 Significant difference between
methods
Shell vials &
Histology
-0.0191 0.3173 No significant difference between
methods.
qPCR & IHC 0.0874 < 0.0001 Significant difference between
methods
Shell vials & IHC -0.0305 0.6547 No significant difference between
methods.
Shell vials & qPCR 0.129 < 0.0001 Significant difference between
methods
3.10 Time- and Cost Analysis
Formal quotes from the National Health Laboratory Services (NHLS) for the three
methods used (shell vial cultures, real-time PCR and IHC) are attached (Addendums
D and E).
The minimum time required for one test (including preparation time, incubation time
and running time on the instrument), as well as the cost for each method, is indicated
(including IHC processing) in Table 3.6. Although these times are for a single test,
most samples are batched to save costs and time. The maximum time from when a
sample is received until a result is available is also indicated.
An important factor which was not considered by this study, is the possibility of using
multiplex real-time PCRs. This method will decrease the cost for the detection of
viruses by means of real-time PCR considerably as more than one virus can be
detected by one PCR. A single PCR might have a higher cost, due to the complexity
of developing this type of PCR, but it will still be less expensive than performing
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different PCRs for each different virus. More research into the development of
multiplex PCRs for detection of multiple viruses in SUDI cases is thus definitely
justified.
Table 3.4: Time and cost analysis for diagnostic methods
Method Minimum
Time Needed
Maximum
Time Needed
Cost per sample
(NHLS)
Shell vial culture 48 hours* 48 hours* ~R200 – R400
Real-time PCR 8 hours* 48 hours* ~R550
IHC (excl. processing) 24 hours** 48 hours** ~R380
IHC (incl. processing) 24 hours** 48 hours** ~R560
* Personal communication – Ms Mathilda Claassen, Chief Medical Technologist,
NHLS
** Personal communication – Ms Charlene Williams, Immunohistochemistry
laboratory manager, Pathcare
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Chapter Four
4. DISCUSSION AND CONCLUSION
4.1 Discussion
4.1.1 Introduction
The objective of this study was to compare three different laboratory assays, i.e. shell
vial cultures, real-time PCR and IHC, for the detection of three different viruses in
lung tissue of SUDI cases. These viruses, CMV, adenovirus and RSV, are known to
cause respiratory disease and pneumonitis in children and especially infants. It is
possible that viral pneumonitis accounts for many deaths of infants younger than one
year old, but that the current routine method, shell vial cultures, may not be sensitive
enough to confirm positive infections (Erice et al., 1992; Mazulli et al., 1993;
Pedneault et al., 1996). Therefore, many deaths are attributed to SIDS rather than
having a known cause of death, even though there is a cause of death, but the method
of detection is just not able to confirm it. Eighty-two (82) lung samples were collected
from SUDI cases and were tested in parallel. The major findings will be discussed in
this chapter.
4.1.2 Retrospective Audit
A difference between the retrospective audit and the prospective study for the amount
of SUDI cases positive for adenovirus on shell vial cultures is evident. If one
considers that the time delay between autopsy and laboratory tests were significantly
lower during the prospective study, because SUDI samples were collected directly
from the mortuary and taken to the laboratory for immediate testing instead of being
couriered, this is quite an unexpected finding.
However, it must be taken into account that the retrospective study reviewed cases of
three full years, including all seasons whereas the prospective study only reviewed
cases seen in a nine month period. Thus, in the prospective study, no cases were
collected during winter. It is unfortunately not possible to directly compare the
number of cases per season with each other, as the date of death of babies included in
the retrospective study is not available and therefore no conclusion about the season in
which death occurred is available.
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4.1.3 Demographic Data
The majority of SUDI cases (58%) in this study were male. This finding corresponds
with the literature, indicating that male gender shows a slight predomination in SIDS
cohorts (Kinney & Thach, 2009; Raza & Blackwell, 1999; Thach, 2008; Unger et al.,
2003). The reason for this phenomenon is unclear and further research into the
reasons for the gender distribution is required.
Ethnic distribution included predominantly black infants with 66% and infants with
mixed ancestry (coloured) making up 33% of the total. Only one infant (1%) was
white. Certain ethnic groups are more prone to SIDS (Blackwell et al., 2004) and
black infants and infants of mixed ancestry (coloured) are singled out by Kinney &
Thach (2009) to be at higher risk than other infants. It is however postulated that this
tendency is not the only reason responsible for the ethnic distribution in this particular
study, but also the geographical area covered by the Tygerberg mortuary as areas such
as Khayelitsha, Mfuleni and Delft, where a similar ethnic distribution can be found,
are included in this region. These findings are however also similar to a different
study performed in South Africa, which compared the demographic profiles of SUDI
cases in Pretoria and Tygerberg (Du Toit-Prinsloo et al., 2010).
The mean age of the infants was 2.9±2.6 months and median age was 2 months. This
is in accordance with the literature that SIDS deaths reach a peak at three months
(Blackwell et al., 2004; Kinney & Thach, 2009). A possible explanation for the age
distribution of SUDI cases could include that maternity leave is only two to three
months after which mothers have to leave their babies at daycare centres etc. where
there are sometimes multiple babies/children and individual attention is not given to
infants. A more likely explanation is the maturation of the central nervous system
(CNS) as well as different immune responses of the infant. Whatever possible reasons
exist for the peak of SIDS cases between two and four months, it is clear that this is a
multifactorial phenomenon.
Published literature shows that lower socio-economic circumstances places infants at
higher risk for SIDS (Blackwell & Weir, 1999; Blackwell et al., 2004; Dwyer &
Ponsonby, 2009; Kinney & Thach, 2009). There are many possible explanations for
poor socio-economic circumstances being a risk factor; this includes malnutrition
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which could play a role in acquiring infections, also exposure to multiple pathogens
and even domestic violence, which is common in such settings. All SUDI cases were
collected from the Tygerberg area with the largest number of cases (n = 24) obtained
from Khayelitsha, a predominantly black township. Kraaifontein and Delft followed
with ten cases each and Mfuleni contributed eight cases to the study. According to the
5 Year Integrated Development Plan published by the City of Cape Town in 2006,
these areas are regarded as having lower socio-economic status.
In 65% of the cases (n = 53), bedsharing with up to three people was reported.
Twenty-four percent (24%, n = 20) of infants were either put to sleep, or were found,
on their stomach. Sleeping in the prone position, as well as bedsharing, has been
recognised as a possible risk factor for SIDS (Bajanowski et al., 2007; Dwyer &
Ponsonby, 2009; Högberg & Bergström, 2000; Kinney & Thach, 2009; Mitchell,
2009). The Back-to-Sleep campaign, which was launched in 1994, therefore
encouraged mothers to place their babies on their backs to sleep. Although the
dangers of bedsharing and prone sleeping position are widely known, it is possible
that many of the parents of the SUDI cases in this study are not aware of these
dangers. As previously mentioned, the majority of SUDI cases in this study are from
low socio-economic areas (5 Year Integrated Development Plan, City of Cape Town,
2006). New mothers might not be aware that it may be detrimental to place young
infants in the prone position, or why they should not allow the infant to co-sleep with
them. Another problem in these areas is overcrowding, where there is often only one
bed available in a home and bedsharing is inevitable (Randall et al., 2009).
Even though all mothers were interviewed before the autopsy of their babies and
asked whether they knew the dangers of cigarette smoke and alcohol use during
pregnancy and all confirmed that they did, alcohol use and cigarette smoke during
time of conception and pregnancy were reported in 24% (n = 20) and 29% (n = 24) of
the cases respectively. One mother admitted to using other types of drugs, including
marijuana and methamphetamine (street name: tik) during pregnancy. Maternal
smoking is reported to be the most preventable risk factor for SUDI (Matturri et al.,
2006) and therefore education of new mothers are of vital importance to prevent
SUDI.
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At least 28% (n = 23) of the cases were reported to be ill at least 24 hours prior to
death. Illness included vomiting, rhinorrhoea, coughing, pyrexia and diarrhoea.
Although these symptoms are probably not enough to independently cause death, the
underlying cause (i.e. an infection) might be a contributing factor to death. Especially
rhinorrhoea and coughing might be an indication of a respiratory infection, and proper
screening for respiratory viruses is therefore very important. It is also important to
keep in mind the three-hit model/triple risk hypothesis, which suggests that an
infection might be the trigger of a genetic predisposition to SIDS (Opdal & Rognum,
2004).
4.1.4 Laboratory Assays
Bajanowski et al. (2007) recommended that two samples (one peripheral and one
central) of each of the five lung lobes should be taken for histology in all SIDS cases.
They further recommended that two samples be taken of the lung parenchyma and one
of the lower trachea for IHC, PCR and other purposes, such as genetic testing
(Bajanowski et al., 2007). The current protocol at the Tygerberg mortuary is to take
swabs from the left lower lung lobe for bacterial cultures and to send a piece of that
same tissue, as well as a piece of liver, for virological testing. The lack of a national
protocol for the investigation of SUDI cases in South Africa (Du Toit-Prinsloo et al.,
2010) leaves institutions to determine their own protocols in the handling of such
cases.
Shell vial cultures are still regarded as the gold standard for respiratory virus detection
in some settings (Lee et al., 2010). This method was initially developed to speed up
the detection of CMV, which can take up to 30 days on conventional cell cultures
before the virus can be detected, but is now used for a variety of viruses including
adenovirus, RSV and other respiratory viruses (Leland & Ginocchio, 2007). Shell vial
cultures are however known to be less sensitive for the detection of CMV infections
than conventional cell culture and other methods of detection (Erice et al., 1992;
Mazulli et al., 1993; Pedneault et al., 1996). This was also observed in this study
when only three samples were found to be positive for CMV. No samples were
positive for either adenovirus or RSV, which could mean that either all samples were
truly negative for the presence of these viruses or that shell vial cultures are not
sensitive and specific enough for the detection of these two viruses. The lack of a gold
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standard for the investigation of viral infections specifically in SUDI cases makes it
very difficult to interpret results such as these because there is no information about
the sensitivity and specificity of the assay. Thus the agreement between methods is
very important to make an educated guess as to which method is better suited for
diagnostic purposes.
Considering the shell vial results for all three viruses, an infection could only be
confirmed in three cases. Of these three positive viral infections, only one had an
interstitial pneumonitis diagnosed by a forensic pathologist as seen on H&E stains,
severe enough (i.e. grade 2 or 3) to cause death. Thus, only one case was successful in
determining a possible cause of death. Virus infections, specifically CMV, adenovirus
and RSV, have been mentioned numerous times to be prevalent in SUDI cases
(Bajanowski et al., 2007; Highet, 2008; Samuals, 2003; Weber et al., 2010) and
therefore a this low positivity rate raises questions about possible positive infections
not being detected. The fact that post-mortem tissue is involved should be considered
in the explanation of this low positivity due to the fact that degradation of tissue as a
result of delays between death and the laboratory assay might hinder viral detection.
There is however not currently a suitable solution for this problem and therefore the
correlation of any positive results with H&E, which gives a picture of the pathology in
the lung at the time of death, is of vital importance.
Even though shell vials have a very low positive yield which one would expect to be
higher, this is the most inexpensive method currently available. In a resource limited
country this is an important factor which carries a lot of weight in the decision of
which method is best.
Real-time PCR is widely considered to be the gold standard for the detection of
infectious pathogens (Álvarez-Lafuente et al., 2008). It is quicker than conventional
methods (Leland & Ginocchio, 2007) and has a higher sensitivity (Jeffery & Aarons,
2009), but is unfortunately a very expensive method. In our study, real-time PCR
revealed far more positive CMV infections than any of the other methods and has,
potentially, a much faster turnaround time than both shell vial cultures and IHC. The
implication of a positive HHV, in this case CMV, should however be very carefully
considered. As previously discussed, PCR methods can detect the presence of the
virus, even though the infection is not clinically relevant. This could be due to either
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the detection of a latent virus (i.e. asymptomatic period with little or no replication
and no viral antigen expressed) or that of a reactivated virus. Even though reactivation
in infants is not very likely since their young age would lead one to believe that
infection is due to primary infection, this factor cannot be proved and thus cannot be
discarded.
A total of 29 positive CMV cases were confirmed compared to two positive cases on
shell vials and two on IHC. The latter methods did not indicate the same samples as
being positive for CMV, but real-time PCR confirmed positives with both shell vials
and IHC.
The difference between the different methods (considering positive yield) is
statistically highly significant when real-time PCR is compared with either shell vial
cultures or IHC (Kappa Statistical Test: Pr>S = 0.0001) and shows that there is not
good agreement between real-time PCR and both the other methods of viral detection
(Table 3.5). This highly significant p-value indicates that there is a great difference
between the detection yields of the different methods, therefore illustrating that one
method is detecting positives (true and/or false positives) the other is not. Again, it
must be kept in mind that these positive results are not necessarily indicative of
clinical disease, only of the presence of the virus in the body.
There are two possible reasons for the differences between the methods of viral
detection. One could be that the specificity of the CMV real-time PCR assay is low
and thus false positives are detected, leading to a very high number of seemingly
positive CMV infections. However, this is not a likely explanation: the primers and
probe for the CMV real-time PCR were obtained from a published article by Preiser et
al. (2003) who specifically tested the assay against other HHV’s to ensure that it has a
high specificity, which was indeed the case. The fact that a specific probe is used in
real-time PCR also increases the assay’s specificity (Preiser et al., 2003). These facts
therefore show that the CMV real-time PCR did not detect false positives and that a
low specificity can therefore not be to blamed for the high number of positive CMV
cases compared to the other two methods.
Another reason for the big difference in positive yields between methods is probably
that the PCR method is able to detect not only active infections, but also latent
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infections (Griffiths, 2009), an asymptomatic period where little or no replication of
the virus occurs. Latent infections are not necessarily clinically relevant (Griffiths,
2009) and whether a latent CMV infection can actually contribute to death even
though it did not cause death directly, is an unanswered question which requires
further research (Dettmeyer et al., 2008). It has been reported that PCR methods are
often too sensitive for clinical use in the detection of CMV (Machida et al., 2000).
Our study confirmed that to identity a direct cause of death, real-time PCR used
qualitatively is not optimal for the purpose of diagnosing CMV infections since there
cannot be distinguished between active and latent infections and thus clinically
relevant and non-relevant infecetions. Therefore the clinical significance of a positive
result is unknown. Conventional PCR would have the same problem, and therefore a
possible solution would be to use real-time PCR quantitatively.
At the Forensic Pathology Division of Tygerberg Hospital, all results are correlated
with the findings of the microscopic evaluation of H&E stains and positive virological
results may be discarded if the H&E does not also indicate changes in the lung that
suggest an infection. Using a method that detects latent infections will therefore not
necessarily contribute to the overall diagnosis, because there will be no virological
changes in the lung that can be detected on histology, without an active viral
infection.
Seven of the 29 positive CMV cases showed, as diagnosed on histology slides, an
interstitial pneumonitis of either grade 2 or 3, a pneumonitis severe enough to cause
death. Although this is not a statistically significant value (Pearson Chi-square test: p
= 0.06605), there could indeed be an association between the two factors (Figure
3.12), which should be confirmed in larger studies with more cases. However, it must
also be kept in mind that, although more cases as seen with the other methods, still
only a small percentage (24%, n = 7) of positive CMV infections (as tested by real-
time PCR) had pneumonitis severe enough to cause death. This leads to the question
of how specific this method is for the prediction of pneumonitis. If it was indeed as
specific for the prediction of pneumonitis as initially thought, a much higher
agreement between positivity and grade 2/3 interstitial pneumonitis would have been
seen. Thus, the method might be very sensitive in detection of CMV but it might not
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be very specific in the prediction of whether the CMV detected is relevant and
therefore indicate non-relevant infection as being relevant.
Yet again, the possibility of association between CMV infection and severe interstitial
pneumonitis, as well as the specificity of real-time PCR in the prediction of
pneumonitis should be further researched to draw any significant conclusions. The
ideal method in the detection of CMV in SUDI cases would be one with a high
sensitivity and specificity, but also a high positive and negative predictive value.
Using real-time PCR quantitatively might be a good indicator of whether CMV can be
held responsible for viral pneumonitis or whether there might be other causes to
consider and therefore this method might solve some of the abovementioned
problems.
Two samples were positive for adenovirus using qualitative real-time PCR but neither
of these cases had a grade 2/3 interstitial pneumonitis. If the tests had been done for
routine diagnostic purposes, the results would have been disregarded and not
considered in the final diagnosis of death. This low positive yield of adenovirus in
SUDI cases was also found in a previous study which used IHC and PCR for viral
detection (Dettmeyer et al., 2004). This poses the question of whether adenovirus is
not a virus commonly found in SUDI cases in a South African setting or whether none
of the methods are ideal in the detection of adenovirus. It must also be kept in mind
that no samples were collected during winter and this could explain why so few
positives were detected, especially if it is compared with the retrospective audit where
six cases of adenovirus were found in a three-year period. Since adenovirus is more
prevalent during winter months (Echavarrìa, 2009) this is a plausible explanation.
No RSV could be confirmed with real-time PCR. The sensitivity of the primers and
probe used might be in question, but since it forms part of a multiplex PCR for the
detection of multiple viruses designed for use in a clinical setting (Watzinger et al.,
2004), this is not a likely explanation. The fact that so few samples were positive for
the presence of RSV by means of real-time PCR might indicate that RSV, similar to
adenovirus, is not a virus commonly found in SUDI cases in a South African setting.
The reason for this is unclear and this finding needs to be ratified by larger studies
which consists of more cases, is multi-centred (and thus covers not only an area of the
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Western Cape, but also all other provinces in South Africa) and that runs over several
years (to include not only different calendar seasons, but different “flu seasons” as
well).
IHC can be used as an aid in routine histological examination of H&E stains
(Dettmeyer et al., 2008) and that was confirmed in this study where IHC detected
slightly more CMV positives than routine H&E stains. Two samples were positive for
the presence of CMV when tested with IHC and macrophages were clear in one and
CMV inclusion bodies were clear in both cases. Both macrophages and inclusion
bodies are typically found in CMV infections. One of the two cases also had a grade
2/3 interstitial pneumonitis. Therefore IHC, when testing for CMV, had similar results
to shell vial cultures: contributing a possible cause of death due to CMV infection, to
one case. IHC did not reveal the presence of adenovirus in any of the samples. Four
samples were positive for the presence of RSV thus making IHC the only method that
detected this virus in SUDI cases in this study.. However, the positive yield of this
specific test was only 4.9% (n = 4), revealing that even though there is a difference
between the detection rates, there is good agreement between IHC and the other
methods used for the detection of RSV (Table 3.5). Half of the positive RSV cases (n
= 2) also had a grade 2/3 interstitial pneumonitis indicating that a cause of death could
be clarified in only two cases when using IHC as RSV detection method.
Consequently IHC is not ideal for the detection of viral infections in SUDI cases,
detecting six infections out of all 82 cases. Only three of the 6 infections also had a
grade 2/3 interstitial pneumonitis and the infection could possibly be considered the
cause of death. The shortcomings of this particular study should however be kept in
mind, including problems with overfixation and formalin pigment which is not likely
to, but may have contributed to poor positive yields.
Even though IHC seemed to be the best method for the detection of RSV in SUDI
cases since no other method detected the virus at all, there were only 4 positive RSV
infections, which still revealed good agreement between the different methods (Table
3.5).
When considering the results of all three methods for the detection of adenovirus and
RSV, it seems that these viruses are not commonly seen in the Tygerberg area in
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SUDI cases. These viruses have been included in the routine protocol for years and no
research of this type has been performed to prove or disprove the prevalence of the
viruses in the Tygerberg area until now. This finding also correspondeds with the
retrospective audit (Section 3.2) where six cases were positive for adenovirus and
only one for RSV, over a period of three years. This indicates that the positive yield
for adenovirus and RSV is low consistently over a period of time. All three methods
used in this study are either gold standards for other detection purposes or known for
its sensitivity and thus agreement between them, that the viruses are rare in this
setting, should be seriously considered. The detection of adenovirus in two cases did
not contribute at all to a possible diagnosis of death and only two RSV were
recognised for its possible involvement in death. However, it must be kept in mind
that this study has several limitations, including a low number of study subjects and
that sample collection did not include winter, a month in which both adenovirus and
RSV are highly prevalent ((Echavarrìa, 2009; Hall, 2009). Thus, the findings observed
in this study should be confirmed, as previously mentioned, by studies with more
subjects and over a period of several years.
When considering only H&E stains it is clear that, as has been discussed before, this
method cannot be used on its own to determine what type of infection is present. It
can only describe changes due to infection. The results of the H&E stains showed a
high prevalence of collapse and congestion in the lungs. Other changes in the lungs
were not significant in that it did not appear often or in most cases. Since congestion
and collapse were highly prevalent, these findings were correlated with the medical
histories as well as whether cases with congestion and/or collapse were positive for
any viruses. The data revealed that infants who were sick prior to death had 27% (n =
16) collapse and 21% (n = 14) congestion. Viral infection together with congestion
and/or collapse was less prevalent, with 29% and 23% respectively. Many of the
structural changes in the lungs which were mentioned are frequently seen in SUDI
cases and are not necessarily related to infection or a cause of death. The reasons for
the changes occurring remains unclear.
When correlating the medical histories of the babies with the results of the different
methods, if was found that in five cases of severe interstitial pneumonitis being
present, the infants displayed symptoms of illness prior to death. Eight positive CMV
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cases and one each of adenovirus and RSV were sick prior to death. These symptoms
included vomiting, rhinorrhoea, coughing, pyrexia and diarrhoea. If these numbers are
considered against the background of how many positive infections was found, it is
not particularly surprising and only serves to underline the questions already asked:
what role does infection play in SUDI and what causes the difference in sick infants
that do not die of infection as opposed to SUDI cases.
4.1.5 Comparison of Laboratory Assays
All this information leads to very important questions. Is the method currently used,
which includes histology being correlated with shell vial results, the ideal method for
the detection of respiratory viruses in SUDI cases? If not, which different method/s
should be used and is it economically justified? Furthermore, to what extent do
viruses play a role in the causation of interstitial pneumonitis and are we in fact
including the wrong viruses by excluding so many other potential viruses in the
routine protocol?
When the positive yield of the three different laboratory tests is considered, the only
test with a significant difference compared to the other methods is real-time PCR
when testing for CMV. However, this technique reveals active as well as latent
infections which might not necessarily be clinically relevant. Also, the problem of
primary versus reactivated CMV infection still remains. Qualitative real-time PCR is
not the recommended method for the detection of CMV in SUDI cases. Different
methods, such as a viral load on real-time PCR or a PP65 antigen test (which detects
the presence of the PP65 antigen which is present during the replication of the CMV
virus and is thus an indication of an active infection), can be used to detect active
infections will thus give more information regarding a specific case and whether a
positive result in fact does have a clinical implication. A latent virus will result in a
very low viral load in a real-time PCR test and this could be a good indication of
whether infection contributed to death or not. There is no specific cut-off viral load
value to determine whether a virus was the cause of death or not, but when it is
considered in conjunction with histology, clinical information and pathologist
opinion, viral load can be a very useful tool in the diagnosis of death.
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Ideally, a method should exist that can solve all abovementioned problems. This
would be a method that has a high positive predictive value (i.e. a positive result that
is truly positive among all positive results) and a high negative predictive value (ie.e a
negative result being truly negative among all detected negative results). This would
then indicate whether positive viral infections have indeed played a role in death or
not. However, on the basis of the methods examined in this study, this is not possible
and therefore a combination of methods, such as which is currently used, might be the
best option to try and detect as many true positive infections which played a role in
causing death. Further research into this matter is thus justified.
4.1.6 Histology – H&E
H&E staining is routine in all SUDI autopsies. Not only are the lungs examined, but
also all other organs which might reveal a possible cause of death, including the brain,
gastrointestinal tract and liver. Many different architectural changes are visible in the
H&E stains of lungs, which can include congestion, collapse, oedema, interstitial
pneumonitis, pneumonia and other.
The histology of all SUDI specimens is thus very important and is used to interpret
any results of additional tests that had been done on tissue, i.e. virology and
microbiology tests. Should the findings of the additional test not correspond with
what is found in the histology of the case, the additional results will be discarded and
not considered in the final diagnosis of death. Architectural changes indicative of
infection are often seen on histology, and further investigations such as virology and
bacteriology might be able to prove the aetiology (Bajanowski et al., 2007). Thus
these tests, such as shell vial cultures etc. aid in the diagnosis of the case. An example
is interstitial pneumonitis, which can be caused by viral infection but also by other
factors. Therefore further tests are needed to confirm whether a virus was indeed the
cause of the interstitial pneumonitis. Should a laboratory test reveal the presence of an
infection, but this is not evident in the histology, it is concluded that the infection did
not cause death and is merely a co-infection. This presence of viral infections, without
them causing death, has been noted before in SUDI cases (Weber et al., 2010). In this
study, a grade 2/3 interstitial pneumonitis was found in twelve (14.6%) of the cases
and eight of the 12 cases (66.7%) were positive for the presence of a viral infection on
one or more methods. This indicates that the specific viral infection might have
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indeed been responsible for the pneumonitis, which caused death in these cases.
Furthermore it indicates that in four cases, the interstitial pneumonitis was not caused
by a viral infection, thus showing how important it is to know whether a virus is
present or not.
An H&E stain on its own and without the backing of other tests is not ideal in the
detection of respiratory virus infections specifically, only for the changes due to viral
infection. Only one stain was positive for CMV on histology and CMV inclusion
bodies were clear in this case. None of the other stains revealed the presence of any of
the other viruses. Histology is however a valuable tool in determining whether an
infection was contributing towards death because architectural changes in the tissue
can indicate whether the effects of infection were life-threatening or not.
4.1.7 Time and Cost Analysis
Although the turnaround time of a specific test is not of vital importance in SUDI
since the results are not required for clinical management of a patient, it is still
important that pathologists receive results as soon as possible to avoid an
accumulation of case reports and results.
Although the processing of samples for shell vial cultures is relatively quick and easy,
the incubation time of this method increases the overall turnaround time until a result
is available to 48 hours. Although real-time PCR has the potential to show results
within 8 hours, many results are only available after 48 hours (Table 3.6), because
samples in a diagnostic setting are mostly tested in batches to save cost and time. IHC
processing and staining for a typical SUDI sample also takes up to 48 hours until
completion. The maximum time needed for any of the three methods is thus 48 hours.
Skilled laboratory staff is needed for all three methods, whether it is to subculture and
interpret shell vial culture results microscopically, to set-up and run a real-time PCR
and be able to interpret results, or to process samples for IHC (a process which is
mostly done on automated systems) and interpret the results.
Table 3.6 summarises the cost of all three methods and formal quotations for the tests
from the NHLS can be found in Addendums D and E.
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The total cost for viral detection in one SUDI case according to the current protocol
adds up to R584.54. This includes the pricing of two cultures and four shell vials
(different cultures are used for CMV and adenovirus/RSV, plus two viruses are tested
for simultaneously per shell vial).
The main disadvantage of using real-time PCR for diagnostic purposes is the high cost
of the method. One test costs R547.68 and therefore the combined cost of testing for
three viruses in SUDI cases, will be approximately R1600. However, an important
factor that should be considered in the case of real-time PCR is the prospect of
developing multiplex real-time PCRs. Although multiplex PCRs are complex to
develop and the cost of a single run might increase slightly, the overall cost of the
detection of multiple viruses will decrease considerably.
IHC staining costs R374.34 per sample, but if the processing of each sample is taken
into account (i.e. processing tissue sample to wax block, cutting of slides etc.), the
cost of one test is R561.51, making IHC the most expensive method of all the tests
used in this study.
There is thus a significant difference in the costs of the different methods. This factor
should be taken into account when considering which method is ideal to use in the
detection of viruses in SUDI cases, especially in a resource-limited setting. Also, the
applicability of the different methods and the cost thereof should be carefully
considered as it will be futile to spend resources on methods that are not proven to be
significantly better in the detection of viral infections in these cases.
The conclusion reached by this study would be to investigate the possibilities of
quantitative multiplex PCRs for the detection of different respiratory viruses and then
compare it with information currently available. This method could then include more
viruses that are currently included in the routine protocol and more information
regarding the viral load of positive infections will be available. Also, more research
on the incidence of some of the viruses mentioned is required so that these viruses can
stay included or be removed from the routine protocol.
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4.1.8 Future research
Although it is known that CMV can cause interstitial pneumonitis (Smith et al.,
1977), the association between CMV infection and severe interstitial pneumonitis,
leading to death, should be further explored. Specific questions that need to be
addressed include at which level of infection and at what specific viral load value is
CMV considered to be able to cause interstitial pneumonitis severe enough to cause
death; and why is CMV asymptomatic in some individuals but cause a severe
pneumonitis in others. If there is a significant association between the amount of
CMV infections that lead to severe interstitial pneumonitis and thus death, it is vital to
detect this early in life to avoid infections severe enough to cause death. It is also
important that an accurate method of detecting CMV infections is used in SUDI cases
to obtain a clear result of whether the virus was the cause of death or not. It is evident
that many problems exist with the detection of CMV regardless of which diagnostic
method is used, and thus this is one of the most important issues that require attention
and further research. A possible solution could be to make use of more than one
method and use this combination to get a more realistic and trustworthy picture of
what role CMV has played in death.
Another factor that might be useful is determining the prevalence of CMV in non-
SUDI related infant deaths. If CMV is shown to be highly prevalent in these cases, it
might indicate that CMV is not related to death. Yet, the triple-risk model (Opdal &
Rognum, 2004) should always be kept in mind.
The literature mentions many other viruses, including HSV, VZV, EBV, HHV-6,
influenza and parainfluenza viruses (Álvarez-Lafuente et al, 2008; Bajanowski et al,
2003; Raza & Blackwell, 1999) which do not form part of the current routine
diagnostic investigation of SUDI cases in South Africa. Research on the incidence of
these viruses in SUDI cases could prove very valuable to adjust the routine diagnosis
for viral infections. The consequence of HIV should also be investigated to determine
what influence this virus, specifically in South Africa, has on SUDI cases.
The possibility and development of a multiplex real-time PCR that include all viruses
that are implicated in SUDI can prove to be very valuable since it will not only
decrease the cost, but it will also save time, since different tests would not be needed.
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Another important factor in future SUDI research is the need for a method or
combination of methods that is specific not only for the viruses it tests for, but also for
the prediction of whether a positive result is in fact meaningful.
It is important to remember that even though the presence of a viral agent might not
be enough to cause severe illness and death, the mere presence could be the trigger
that offsets the three-hit model/triple risk hypothesis (Opdal & Rognum, 2004).
Therefore something that might not seem important, such as a mild viral infection
which can even be completely asymptomatic in most individuals, can in fact
contribute to death even if it didn’t cause death directly. This definitely warrants
further research into the effect the presence of a virus can have in a baby that is
already predisposed to SUDI, especially if the three-hit model (Opdal & Rognum,
2004) is considered.
4.2 Conclusion
In cases of SUDI, no cause of death can be identified by only reviewing the history of
the case or performing an autopsy. Any laboratory tests done are therefore of vital
importance to aid in identifying potential causes of death, which will decrease the
amount of cases that are classified as having no cause of death and thus falling into
the SUDI category. A nationalised protocol of the investigations performed in SUDI
cases is also vital, to ensure proper investigations and comparable results of SUDI
cases across South Africa.
The lack of a gold standard for the detection of viral infections in SUDI cases makes
it difficult to determine whether a different method is better suited for this diagnostic
purpose. Specificity and sensitivity of the different methods cannot be determined
without a gold standard because there is no method with known statistical measures
for the new methods to be compared to (regarding true and false positive and negative
results). Therefore only agreement between methods could be assessed without being
able to determine whether one method is statistically better than another. All that is
possible is making an educated guess, based on the results as well as previous
research, to decide which method is better suited for this specific purpose.
If the results of all the tests are considered, it is clear that more research into the
prevalence of the different viruses in SUDI cases of the Western Province, Tygerberg
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are. Also, no single method seems to be ideal for the detection of any of the current
viruses included in the routine protocol and therefore an investigation into which
method or combination of methods is best, should be investigated.
Using this method in SUDI cases cannot be compared to the usage in other routine
applications since the circumstances regarding the test differ greatly. One difference
between the methods is the type of sample used: post-mortem lung tissue, which
might already have begun degrading or might be overgrown by post mortem flora, is
used in SUDI cases. Other samples, such as urine, stool, nasal and throat swabs and
tracheal aspirates are obtained directly from a live patient to be used in other
applications. Even though a direct comparison cannot be made, data mining of all
shell vial results, in the same laboratory, over the same period as this study revealed
that only 4.7% of cases were positive when tested for CMV, 3.3% showed an
adenovirus infection and 5.7% of all combi shell vials were positive for RSV. These
results correspond with the low positive yields found in this study, but leads to
questions about the validity of the shell vial culture method.
The study further concludes that IHC might not be a good option for the routine
detection of viruses either. Although this method revealed more RSV infections than
any of the other two methods, the positive yield is still too low to justify the high cost
of the method.
Real-time PCR might be a good option for the routine detection of respiratory viruses,
but it is important to distinguish between active and latent viral infections. By using
quantitative real-time PCR, not only the presence of a specific virus can be confirmed,
but also the viral load. This approach should alleviate the problem of detecting latent
viruses, such as HHVs. Latent viruses will cause a very low viral load, whereas active
viruses will have a high viral load. This will also aid the pathologist in making a
decision on whether a viral infection was severe enough to cause death.
Unfortunately, real-time PCR is a very expensive method and thus investigation into
the development of multiplex PCRs is required. Not only will it decrease the cost of
the detection of different viruses, but more viruses can be included in the assay.
Currently, the routine diagnosis of viral infections in SUDI cases includes testing for
CMV, adenovirus and RSV. As previously mentioned, these viruses are mentioned in
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the literature to be prevalent in SUDI cases and therefore have been included in the
routine protocol at Tygerberg mortuary. No research has been undertaken until now to
determine whether these viruses are indeed prevalent in SUDI cases of this specific
area. If the results of this study, as well as other published studies are taken into
account, it seems adenovirus and RSV are not commonly found in SUDI cases,
especially in a South African setting. These should however be confirmed by larger
studies as this study was relatively small.
The major limitation of this study was the relatively small sample size of only 82
subjects. A larger study should be able to show clearer statistical differences between
variables, such as CMV positivity and grade 2/3 interstitial pneumonia. Also, larger
studies, over several years, might indicate whether adenovirus and RSV are indeed
scarce in this particular setting, as well as what influence the different seasons have on
viral prevalence. Another limitation was that only the left lower lung lobes of SUDI
cases were used since this is the lobe routinely used for viral and bacterial detection.
Obtaining and combining small samples from each lung lobe and using that for
pathogen detection might give a better overall view of the flora found in the lungs.
The lack of a gold standard in the routine testing for viral presence in SUDI cases at
Tygerberg mortuary poses another limitation, because the sensitivity and specificity of
the different methods used could not be calculated.
There are a few recommendations sprouting from this study: The first is to develop
multiplex PCRs for the detection of viral infections in SUDI cases. More viruses can
then be included and the overall cost of the assay will decrease. The second
suggestion is to determine to what extent CMV is present in non-SUDI related deaths.
This will answer important questions about whether CMV might be as involved in
SUDI as suspected. Another related suggestion is further research on the relationship
between CMV infection and severe interstitial pneumonitis and to what degree CMV
is responsible for the presence of pneumonitis.
It is hoped that this study will contribute to the streamlining of investigation into the
viral causes of death in SUDI, our institutional SIDS investigation protocol, as well as
the standardisation of a national SIDS investigation protocol.
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Addendum B: Weight of left lower lung lobe of SUDI cases.
Study Number LLL Weight (g)
N046/02/09-001 20.30
N046/02/09-002 21.31
N046/02/09-003 27.15
N046/02/09-004 15.82
N046/02/09-005 20.01
N046/02/09-006 11.04
N046/02/09-007 9.24
N046/02/09-008 19.89
N046/02/09-009 30.26
N046/02/09-010 31.09
N046/02/09-011 14.09
N046/02/09-012 15.50
N046/02/09-013 19.79
N046/02/09-014 33.52
N046/02/09-015 26.95
N046/02/09-016 21.63
N046/02/09-017 25.14
N046/02/09-018 12.51
N046/02/09-019 23.16
N046/02/09-020 9.45
N046/02/09-021 29.23
N046/02/09-022 7.63
N046/02/09-023 28.72
N046/02/09-024 23.69
N046/02/09-025 24.46
N046/02/09-026 30.33
N046/02/09-027 18.20
N046/02/09-028 15.74
N046/02/09-029 43.88
N046/02/09-030 33.54
N046/02/09-031 38.91
N046/02/09-032 16.98
N046/02/09-033 36.12
N046/02/09-034 15.93
N046/02/09-035 35.13
N046/02/09-036 26.48
N046/02/09-037 19.97
N046/02/09-038 24.71
N046/02/09-039 12.63
N046/02/09-040 13.36
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Study Number LLL Weight (g)
N046/02/09-041 15.06
N046/02/09-042 13.88
N046/02/09-043 31.6
N046/02/09-044 26.80
N046/02/09-045 10.66
N046/02/09-046 51.79
N046/02/09-047 22.53
N046/02/09-048 9.75
N046/02/09-049 23.16
N046/02/09-050 27.70
N046/02/09-051 19.46
N046/02/09-052 30.75
N046/02/09-053 14.15
N046/02/09-054 17.02
N046/02/09-055 22.34
N046/02/09-056 29.59
N046/02/09-057 29.05
N046/02/09-058 16.53
N046/02/09-059 10.10
N046/02/09-060 13.64
N046/02/09-061 19.37
N046/02/09-062 14.88
N046/02/09-063 24.49
N046/02/09-064 46.59
N046/02/09-065 19.90
N046/02/09-066 26.64
N046/02/09-067 27.27
N046/02/09-068 29.23
N046/02/09-069 25.84
N046/02/09-070 13.55
N046/02/09-071 N/A*
N046/02/09-072 25.38
N046/02/09-073 22.37
N046/02/09-074 36.40
N046/02/09-075 11.88
N046/02/09-076 12.98
N046/02/09-077 36.05
N046/02/09-078 32.48
N046/02/09-079 24.39
N046/02/09-080 27.21
N046/02/09-081 14.24
N046/02/09-082 12.82
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* - Due to only a sample of the lung received from the mortuary instead of the entire
LLL, the weight of the lobe could not be established.
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Addendum C: DNA & RNA Concentrations
Sample Number DNA concentration (ng/µl) RNA concentration (ng/µl)
N046/02/09-001 85.7 545.1
N046/02/09-002 34.5 45.3
N046/02/09-003 53.1 128.1
N046/02/09-004 41.8 534.6
N046/02/09-005 88.1 156.6
N046/02/09-006 122.1 397.8
N046/02/09-007 92.7 97.3
N046/02/09-008 55.7 55.9
N046/02/09-009 42.3 30.6
N046/02/09-010 41.7 92.6
N046/02/09-011 43.9 86.4
N046/02/09-012 36.1 69.2
N046/02/09-013 116.1 118.2
N046/02/09-014 49.5 122.2
N046/02/09-015 37.2 86.1
N046/02/09-016 152.0 104.2
N046/02/09-017 42.8 31.6
N046/02/09-018 165.6 271.6
N046/02/09-019 25.2 72.9
N046/02/09-020 40.0 58.9
N046/02/09-021 53.3 160.8
N046/02/09-022 88.7 41.4
N046/02/09-023 55.1 68.1
N046/02/09-024 39.6 24.6
N046/02/09-025 33.3 66.9
N046/02/09-026 31.1 70.4
N046/02/09-027 55.4 94.4
N046/02/09-028 21.6 59.9
N046/02/09-029 13.7 97.9
N046/02/09-030 34.8 44.4
N046/02/09-031 6.4 46.2
N046/02/09-032 110.1 43.2
N046/02/09-033 7.6 53.4
N046/02/09-034 20.9 56.8
N046/02/09-035 11.3 40.4
N046/02/09-036 15.6 30.7
N046/02/09-037 14.1 112.9
N046/02/09-038 39.4 167.0
N046/02/09-039 35.8 63.1
N046/02/09-040 21.4 160.7
N046/02/09-041 22.2 40.1
N046/02/09-042 74.0 75.1
N046/02/09-043 51.3 208.7
N046/02/09-044 49.2 49.2
N046/02/09-045 82.1 77.4
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Sample Number DNA concentration (ng/µl) RNA concentration (ng/µl)
N046/02/09-046 33.9 99.0
N046/02/09-047 238.9 62.5
N046/02/09-048 60.4 159.1
N046/02/09-049 83.4 77.2
N046/02/09-050 31.8 41.7
N046/02/09-051 17.0 48.1
N046/02/09-052 52.1 31.7
N046/02/09-053 41.6 94.0
N046/02/09-054 132.0 76.7
N046/02/09-055 38.2 64.3
N046/02/09-056 27.2 47.9
N046/02/09-057 121.1 119.6
N046/02/09-058 39.8 142.3
N046/02/09-059 36.9 48.4
N046/02/09-060 68.8 57.6
N046/02/09-061 247.6 129.8
N046/02/09-062 84.4 73.2
N046/02/09-063 43.5 176.6
N046/02/09-064 66.6 8.4
N046/02/09-065 44.8 29.8
N046/02/09-066 128.6 19.6
N046/02/09-067 30.3 38.5
N046/02/09-068 174.2 76.0
N046/02/09-069 41.0 133.8
N046/02/09-070 40.3 11.8
N046/02/09-071 20.9 91.0
N046/02/09-072 119.1 90.6
N046/02/09-073 153.0 172.4
N046/02/09-074 28.8 93.7
N046/02/09-075 35.2 166.8
N046/02/09-076 34.3 75.2
N046/02/09-077 157.7 91.1
N046/02/09-078 42.6 10.9
N046/02/09-079 20.2 72.5
N046/02/09-080 54.1 75.4
N046/02/09-081 29.2 16.6
N046/02/09-082 35.4 99.1
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Addendum D: NHLS Quotations - Shell vial cultures & Real-time PCR
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Addendum E: NHLS Quotations - Processing and staining of IHC
